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Abstract 
Maintaining the tertiary structure of the protein, by careful control of buffers and 
instrumental conditions, complexes formed in the solution phase can be transferred 
to the gas phase and subsequently analysed and detected by a mass spectrometer. 
The work presented here probes a variety of non-covalent interacting biological 
systems by electrospray ionisation mass spectrometry (ESIMS). Two systems were 
studied in depth. 
Cyclophilin A (CypA), an important protein in the immune system which forms a 
strong non covalent complex with Cyclosporin (CsA). Conditions required to 
preserve the complex between CypA and CsA were investigated. The optimised 
conditions were used to analyse a variety of CsA peptides analogues and synthetic 
mimics' affinity for CypA, culminating in the screening of a combinatorial library of 
potential CypA inhibitors. 
Calmodulin (CaM) is an acidic ubiquitous calcium binding protein, which undergoes 
a large conformation change upon binding four Ca 2+  ions. Ca 2+ loaded CaM interacts 
with nitric oxide synthase (NOS) enzymes, which in turn control the production of 
the signalling molecule and cytotoxin NO. The interactions between CaM and the 
flavin mononucleotide (FMN) binding domain of nNOS are probed by ESIMS and 
the 46 kDa complex formed by CaM:nNOS was observed in the gas phase. This is 
shown to be exclusively selective for CaM:4Ca 2 . Further characterisation of this 
system is afforded by examining a complex of CaM with a 22 residue synthetic 
peptide which is the proposed CaM binding site of nNOS. The strength of the 
interaction was examined using collision induced dissociation at a variety of charge 
states. 
Affinities of magnesium, strontium, lead, and cadmium for the calcium binding sites 
of CaM have also been investigated by ESIMS. All of these divalent cations behave 
differently with respect to CaM. 
Analysis of non covalent interactions by ESIMS is shown to be a powerful technique 
which compliments other physical structural analysis techniques and opens new 
avenues to study effects of toxic metal ion binding. 
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Deciphering the human genome has been a great achievement and a huge step 
forward to further understanding and research into cellular biology. Nevertheless, 
this wealth of information ultimately raises more questions than it answers. A 
human has roughly 30,000 - 40,000 genes in its DNA, only twice as many as a less 
accomplished lifeform, such as worm or fly (1). However, these 30 thousand human 
genes are thought to give rise to as many as 1 million proteins once the myriad of 
post translational modifications have been taken into consideration. This implies that 
it is the regulation of gene products and their interactions which is responsible for the 
increased biological complexity of higher organisms. The study of these proteins, 
which is termed proteomics, is a complicated process which cannot rely on gene 
sequencing alone. 
Proteins are complicated and have four levels of structure (2) shown in figure 1.01: 
• Primary structure - sequence of amino acids that form the polymer. 
• Secondary structure - regions of repetitive 3D structure such as cc-helix and 
13-sheets. 
• Tertiary structure - packing of secondary structure by way of their side 
chains folding. 
• Quaternary structure - identical or different polypeptide chains packing 
together to form dimers, trimers and higher multimers. 
Gene sequence will predict coding regions and hence primary structure but alone it 
does not provide information about post translational modifications or secondary, 
tertiary and quaternary structure that are fundamental to the activity and function of 
the protein. 
Two approaches have been taken to examine protein structure; 'top down' 
sequencing and 'bottom up' sequencing. Top down studies involve studying the 
whole protein, then either 'cutting' or dissociating the protein into smaller pieces or 
domains and studying them. Bottom up methodologies involve digesting the protein 
into small pieces and analysing the primary sequence, before piecing together the 
information. In this work top down characterisation of a series of protein complexes 
is performed using electrospray ionisation mass spectrometry. 
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(a) Primary structure 	 (b) Secondary structure 
- Ala - (II u - Val —Thr - Asp - Pro (I ly- 
13 sheet 
(c) Tertiary structure (d) Quaternary Structure 
Domain 
Figure 1.01 	Illustration of the different levels of protein structure. 
1.1 Mass Spectrometry 
Mass spectrometry (MS) has established itself as a routine method of analysis 
available in the majority of science organisations. A mass spectrometer is defined as 
"An instrument in which ions are analysed according to their mass-to-charge ratio 
and in which the number of ions is determined electronically"(3). Initially mass 
spectrometry was used to analyse volatile molecules which could easily be 
transferred to the gas phase by heating, and then ionised by electron impact. The 
introduction of desorption techniques with fast energy deposition onto the sample 
allowed non-volatile molecules to be studied. Mass spectrometry was still confined 
to the realm of small molecules as more energy was required to transfer 
macromolecules into the gas phase than energy needed to break up the molecule. 
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With the development of mild ionisation techniques in the 1980's ionisation of 
macromolecules, such as proteins, became achievable (4). This advance has so 
revolutionised mass spectrometry that half of the Nobel Prize in Chemistry in 2002 
(5) was awarded to John Fenn and Koichi Tanaka "for their development of soft 
desorption ionisation methods for mass spectrometric analyses of biological 
macromolecules". 
Source —+ Analyser —+ Detector _+Computcr 
Figure 1.02 Components of a mass spectrometer 
Mass spectrometers all consist of three common parts indicated in figure 1.02: an 
ionisation source to introduce the ions into the gas phase, an analyser to separate the 
ions by their mass to charge ratio (m/z) and a detector to count the ions. Latterly, the 
addition of a computer to control the instrument, process the data, and produce a 
mass spectrum in an interpretable form, has greatly assisted the use of MS's. 
1.1.1 lonisation sources 
Ion sources convert a neutral molecule into an ion through electron capture, electron 
ejection, protonation or deprotonation. They are often responsible for transferring 
the molecule into the gas phase. 
Molecules already in the gas phase can be ionised by electron ionisation and 
chemical ionisation (6). These energetic techniques induce fragmentation of the 
molecule. Samples which are not volatile must be extracted directly from the 
condensed phase to the gas phase. Such direct ion sources can be grouped as two 
types: solid - phase ion sources and liquid - phase ion sources. 
In solid phase ion sources, the sample is often mixed with a matrix to aid ionisation. 
This matrix is often solid, for example in: matrix assisted laser desorption ionisation; 
secondary ion mass spectrometry; field desorption and plasma desorption; however 
can also be a viscous liquid, such as in fast atom bombardment. 
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In liquid phase ion sources, the sample is in solution and is introduced as a nebulised 
spray such as in: atmospheric pressure ionisation; thermospray; and electrospray (6). 
In this work, electrospray ionisation (ESI) and its sister technique nanospray 
ionisation (nEST) are used to ionise protein complexes and hence will be discussed in 
greater depth. 
1.1.2 Electrospray 
Electrospray ionisation (ESI) was developed as an ionisation technique for mass 
spectrometry by John Fenn in 1984 (7) based in earlier work by Dole and co-workers 
in 1968 (8). It is a liquid phase ion source and requires the analyte to be introduced 
in solution. The solvent used must be volatile, commonly either methanol, 
acetonitrile, water or mixtures of these solvents are used. The sample is infused into 
the source through a metal capillary at a low flow rate (normally 1-10 IL/min). A 
strong electric field is created by applying a potential difference (normally 3-4 kV) 
between the tip of the metal capillary and the counter electrode. The electric field 
induces charge accumulation on the surface of the liquid emerging from the 
capillary, which forms a droplet containing the analyte, and then breaks off figure 
1.03. A coaxial flow of gas helps the droplets form a jet. The droplets then either 
pass through a curtain of heated gas and through a cone, or pass through a heated 
capillary into the analyser. 
0 •. 






0~0 0'  
0. 
Figure 1.03 	Electrospray ionisation 
Electrospray ionisation takes place at atmospheric pressure, which causes a technical 
problem in coupling to the analyser compartment of a mass spectrometer which is 
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kept at very low pressure. This is overcome by very small openings in the focussing 
lenses between compartments and having several stages of differential pumping. 
How the ions are released from the charged droplet and into the gas phase is still 
under debate. There are two theories: the charge residue mechanism and the ion 
evaporation mechanism. 
In both mechanisms the charged droplets are heated and the solvent is evaporated 
from the droplet. The droplets decrease in size and the charge density increases, 
until it overcomes the surface tension of the droplet resulting in droplet fission. 
In the charged residue model (CRM) (8, 9) the droplet undergoes solvent evaporation 
and successive fission events until the each droplet only contains a single analyte 
molecule. The remaining solvent in the droplet evaporates, leaving a dry analyte ion. 
The ion evaporation mechanism (IEM) (10) gas phase ions are formed by emission 
from the droplet surface to alleviate the high electric potential as the droplet gets 
smaller. The charges on the droplet are spread equidistantly across the surface of the 
droplet and as the molecule is desorbed from the surface it takes with it the charges 
that it spans on the surface of the droplet. Nohmi and Fenn concluded that only ions 
larger than 5 MDa are formed by the CRM and that smaller ions are formed by IEM 
(11). Recently the discussion has progressed to favour the CRM model for 
macroions such as nondenatured proteins (12, 13). The greatest evidence in support 
of the CRM was provided by de la Mora who revealed that most nondenatured 
proteins observed under conventional ESI conditions had charge states where the 
charge was close to the Rayleigh limit. Work from the Kebarle research group 
progressed this theory by examining how the charge of small ions such as Na and 
NH4 at the surface of the droplet is transferred to the protein. Ammonium acetate, 
which is commonly used for the study of folded protein leaves NT-T 4 ions as charges 
on the surface of the protein, which add themselves to the residues on the surface of 
the protein. The adducts are them dissociate by release to NH 3 in the later stages of 
the source by collisions with other gas molecules (14). 
Introduction. 
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Figure 1.04 	Schematic spectra of a multiple charged ion series 
One of the unique advantages of ESI is that it can produce multiply charged ions. 
This is of significant utility since all mass analyzers differentiate on the basis of 
mass-to-charge ratio (m/z). By detecting multiply charged ions the effective mass 
range can be extended. In this way proteins of 10 kDa can be routinely analysed 
carrying for instance 5 charges. Figure 1.04 shows a theoretical spectra of molecules 
of the same analyte carrying different amounts of charge. 
As mass spectrometers do not measure mass directly, rather mass to charge ratio 
(m/z), in a multiply charged ion it is essential to know the number of charges to 
extrapolate the mass. The calculation is by use of simultaneous equations as shown 
below. 
pi = m/z value for peak one. 
P2 = m/z value for peak two which is adjacent to the right of peak one. 
M = average mass of the analyte. 
m = total mass of an ion. 
z = total charge. 
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These equations can be solved for M and z. Computers and MS software packages 
often can carry out this process and can interpret a spectrum of m/z to a spectrum of 
mass. It is often called the transformed or deconvoluted spectrum. 
1.1.3 Nanoelectrospray 
Nanoelectrospray (nEST) or nanospray, is a variation of electrospray initially 
described by Wilm and Mann in 1996 (15). It differs from electrospray in the droplet 
formation process, however the transition from solvated atoms into gaseous ions is 
the same. 
A small volume, 1-10tL, of sample in solution is loaded into a borosilicate glass (1.2 
mm o.d.) capillary which has been previously pulled to a fine tip. In the initial paper 
(15) a back pressure of 0.8 bar was used to form a droplet at the end of the tip, 
although in later publications no backing pressure has been used (16). A potential 
difference of 800-1000 V is created between the tip and the orifice, with the tip a 
distance of 2-5 mm away from the orifice. The potential on the tip can be controlled 
either by the insertion of a platinum wire into the liquid sample, or by coating the 
outside of the tip with a thin layer of gold and/or palladium. 
Figure 1.05 	Nanospray ionisation. 
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Nanospray differs from electrospray in three main areas, a smaller orifice from which 
the droplets are produced, a lower flow rate and the absence of solvent pumps to 
pump the sample from the tip. These differences result in several advantages, such 
as smaller droplet size which requires a lower degree of desolvation for the 
production of ions, higher tolerance of salt contamination and low sample 
consumption (17). The biggest advantage however is the compatibility of nanospray 
with low sample volume. In many proteomic applications, very small amounts of 
protein are available, and the ability of nanospray to deal with very small volumes is 
a huge advantage over electrospray. 
A disadvantage of nanospray is the irreproducibility of spray and charge distributions 
between needles (16). This is mainly an effect of tip orifice (18) but also depends on 
the distance of the needle from the cone, and the voltage on the needle. De Pauw and 
co-workers found that the larger the capillary - cone distance the more favored are 
the species of high m/z, low charge states. This parameter was linked to capillary 
voltage as the larger the distance of the capillary from the cone, the higher the 
capillary voltage must be to sustain a stable spray. Capillary tips with large orifices 
(5 pM) are most susceptible to fluctuations 
1.1.4 Adductation 
Both electrospray and nanoelectrospray can form adduct ions, as well as protonated 
and deprotonated ions. Adduct ion formation (either catonisation or anionisation) is 
the non covalent addition of a cation such as H, Na t, or K or an anion such as Ci 
or SO4 to a neutral molecule resulting in a charged complex that can be observed by 
mass spectrometry (6). While protonation can be thought of as cationisation, it is 
more commonly used for alkali cations. The addition of a proton to a molecule can 
case fragmentation with little ionisation of the parent molecular ion, as there are 
particularly strong interactions between the often mobile protons and the molecule 
which result in unpredictable transfer of charge to the molecule. This can destabilise 
the molecule and encourage fragmentation. Alkali cations can effectively attach to 
the molecule without forming covalent bonds, and the stabilised charge remains 
localised and a more stable molecular ion is formed. In proteins, adductation is 
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commonly seen on the multiply charged ions. Normally a greater degree of 
adductation is seen at lower charge states. This is due to the retention of a degree of 
tertiary structure which stabilises the adduct binding and vice versa. 
The difference between a metal ion adducting to a protein and specifically 
associating with a site on a protein can be confused and muddied in mass 
spectrometry and this is discussed further in section 5. 
1.1.5 Analysers 
As stated previously (section 1.1 .2) analysers separate ions according to their mass to 
charge ratio. The analyser influences the sensitivity, range and accuracy of the mass 
spectrometer. The sensitivity of the analyser is linked to how efficiently it transmits 
the ions from source to detector. The range is determined by the upper and lower 
m/z limits of the analyser that can be measured. The accuracy of the mass analyser 
is interlinked with its resolving power or resolution. This is the ability of the mass 
spectrometer to distinguish between ions of different mass to charge ratios. 
Resolution (R) can be determined in two different ways. The most common 
definition is given by 




where the ions Ml and M2 are separated by a valley. The height of this valley above 
the baseline is specified and is commonly 10-20%. Another definition uses only one 
peak to determine resolution. Here AM is defined as the peak width at half 
maximum height. Higher resolution gives greater accuracy in either allowing better 
distinction between ions of individual isotopes or for average masses, creating a 







Figure 1.06 The effect of resolution on mass accuracy 
There are five main types of mass analyser: magnetic sector, quadrupole, quadrupole 
ion traps, time of flight, and Fourier transform - ion cyclotron resonance (FT-ICR), 
however, only the analysers used in this project will be discussed here. 
1.1.6 Quadrupole 
The principle of the quadrupole analyser was first forwarded in the 1950's (19), and 
been developed to commercially available instruments through the work of 
Shoulders, Finnegan and Story (20). A quadrupole analyser consists of four 
perfectly parallel rods to which a direct current voltage is applied and a radio 
frequency (RF) potential is imposed. Ions entering the field region will oscillate 
depending upon their mass to charge ratio. Changing the RF potential changes the 
field on the quadrupole and determines which ion reaches the detector. Figure 1.07 
shows the path of different mlz ions entering the quadrupole that is set with a fixed 
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Figure 1.07 Quadrupole mass analyser at fixed RF (6). 
The upper mass limit of a quadrupole depends on the RF amplitude and frequency as 
well as the inscribed diameter of the rod assembly. The largest m/z that can be 
transmitted by a quadrupole is given by: 
M - 7X106Vm 
	
(eqn5) max - f
2 
 r,2 
Where Vm represents the potential applied to the rods (equal to cos(27tft)), 2V m is the 
peak to peak amplitude, f is the frequency and t the time and r 0 is the inner radius 
between the rods. (21). 
Commercial instruments commonly have a mass range of 2-4,000 m/z, however 
recently Robinson and co-workers have extended their mass range to 32,000 m/z by 
adjusting the frequency (21) so they could examine larger protein complexes by 
ESIMS. 
Quadrupole analysers are often used with electrospray ionisation sources, due to their 
ability to operate at high pressures. 
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1.1.7 Time of Flight 
The concept of the linear time of flight (ToF) analyser was described by Stephens in 
1946 (22) and was developed into a commercial instrument, based on the work of 
Wiley and McLaren (23). ToF analysis is based on accelerating a set of ions, with 
the same amount of energy, through a field free region to a detector. The time taken 
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Figure 1.08 	Schematic of a time of flight analyser 
Ions are expelled from the source in packets, and are accelerated by a potential V. 
They enter a field free region of length d before reaching the detector in a time t. As 




— 	 (eqn6) 
t 
This can be used to calculate the mass to charge ratio of an ion with mass m and total 
charge q = ze with the following equation: 
Ek = ze V. = q T' = 	 (eqn 7) 




Which shows that m/z can be calculated from a measurement of t 2, the terms in 
parenthesis being constant. 
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Linear ToF analysers have the advantage of an upper mass range 10 MDa, however 
their resolution decreases with increasing mass. This can be improved by increasing 
the length of the flight path which can be done by extending the flight tube to 1-2 
meters, or by using an electrostatic reflector, or reflectron (24). 
The reflectron corrects the energy dispersion of the ions leaving the source with the 
same m/z ratio. Ions with more kinetic energy will penetrate the reflectron further 
and hence spend more time in the reflectron. Thus, they will reach the detector at the 
same time as slower moving ions of the same m/z which did not spend so long in the 
reflectron. 
Source 	
-3000V -3000V D 	+130V 
etector 
-3000V 
Figure 1.09 ToF instrument equipped with reflectron (25). 
Figure 1.09 shows ions with a given mass with correct kinetic energy - filled squares 
- and ions of the same mass but with a kinetic energy which is too low - open 
squares. Ions will penetrate the reflectron to different depths, and hence arrive at the 
detector at the same time. The reflectron increases the mass resolution at the expense 
of sensitivity and introduces a mass range limitation. Many modem instruments 
have combined linear and reflectron ToF to enable switching between optimum 
sensitivity and resolution, and optimum mass range. 
ToP analysers are often used with MALDI ionisation for biomolecules due to their 
high mass range capacity and their need for pulses of ions. 
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1.1.8 Fourier Transform Ion Cyclotron Resonance 
The Fourier transform ion cyclotron resonances mass spectrometer (FT-ICR MS) 
was first described by Comisarow and Marshall in 1974 (26, 27). It works on the 
principle that in the presence of a uniform magnetic field, ions will be subjected to 
the Lorentz force, which will cause them to move in a circular motion perpendicular 
to the magnetic field. 
Force = qv x B 
	
(eqn 9) 
Figure 1.10 The effect of a magnetic field on positive and negative ions. 
Figure 1.10 above describes the Lorentz force experienced by an ion of mass m, 
velocity v of charge q entering a magnetic field B. As velocity and magnetic field 
are vector quantities, x represents the vector cross product. The rotational frequency 
of the ion can be linked to mlz by the following equation 
qB/m 	(eqn 10) 
The cell of an ICR analyser (figure 1.11) consists of 6 plates: two trapping plates, 
two excitation plates and two detection plates. 
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Trapping plate 2 Trapping plate I 
Detection plate 	 Excitation plate 
Figure 1.11 	FT-ICR cell with trapping plates, excitation plates and detection 
plates. 
Ions enter the cell through a hole in the front trapping plate and are then trapped by 
raised voltages on the front and back trapping plates. Under the influence of the 
magnetic field they begin to rotate. The radius of the cyclotron motion induced 
motion of the ions alone is not large enough to be detected, and the ions cyclotron 
motion is also incoherent, i.e. the ions are orbiting in random phase. Therefore the 
ions are excited prior to detection. A potential is applied between two excitation 
plates, causing all the ions with the same mlz to come into resonance with each other 
and travel in a coherent packet. The excitation also causes the ions to be spiralled 
into a larger radius trajectory. As the ion packet orbits with its increased radius, it 
passes close to the two detection plates, inducing an image charge. The charge 
difference between the two opposite detection plates gives rise to a current. The 
induced current oscillates with a frequency the same as the cyclotron frequency, and 
hence can be used to calculate the m/z of the ion. The amplitude of the current is 
proportional to the number of ions and the charge on the ion. All ions in the cell are 
excited simultaneously by a short broad frequency (broadband) voltage and hence 
must all be detected simultaneously. The output from the detector plates is therefore 
a summation of the signal from all the m/z present in the cell. This signal is 




The main advantages of FT-ICR MS analysers are their unsurpassed mass resolution 
(106) and high mass accuracy (<ppm) (28). Their main disadvantages are poor ion 
transmission and a low upper mass limit. 
Initially, ICR mass spectrometers used electron ionisation to form ions within the 
cell, however nowadays the ionisation is normally performed external to the ion cell 
and ICR mass spectrometers have been coupled to electrospray and MALDI 
ionisation sources. 
1.1.9 Detectors 
FT-ICR mass spectrometers can detect the signal within the analyser, however most 
mass spectrometers require a detector after the analyser. The most commonly used 
detectors generate a signal (current), converting kinetic energy from incident ions 
and generating secondary electrons, which are further amplified. 
The electron multiplier, a common detector, uses a series of dynodes maintained at 
ever increasing potentials. Ions strike the surface, generating an emission of 
electrons. These secondary electrons are attracted towards the next dynode, where 
more secondary electrons are generated, which ultimately results in a cascade of 
electrons. This typically amplifies the current by 106 
The photomultiplier conversion dynode detector is similar to the electron multiplier, 
where ions initially strike a dynode and generate electrons. The electrons then strike 
a phosphorus screen, which analogous to the process in a television set, generates 
photons which are in turn are detected by a photomultiplier. The advantage of the 
photomultiplier is that the tube is sealed in a vacuum, unexposed to the environment 
of the MS and hence less likely to be contaminated. Photomultipliers and electron 







Figure 1.12 	Electron multiplier (top) with cascade of electrons and scintillation 
counter (bottom). 
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(-1O) 
Figure 1.13 	Microchannel plate (29) 
ToF instruments often use Microchannel Plate (MCP) detectors (30). These consist 
of a glass plate with many individual channels. Each channel is comparable to a 
single electron multiplier, and an incident ion hitting a channel on one side of the 
plate produces a charge pulse of about 1000 electrons from the other side of the 
plate. MCP's have a large and plane detection area and only a few MCP channels 
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out of thousands are affected by the detection of a single ion. It is therefore possible 
to detect many ions at the same time, ideal for laser ionisation where hundreds of 
ions can be created within a few nanoseconds. 
1.1.10 Tandem Mass spec 
Mass spectrometers can have more than one analyser, and are often used to analyse 
fragment or daughter ions. Tandem mass spectrometry (MS/MS) allows one to 
select an ion of a desired m/z and to dissociate it and mass analyse the fragment ions. 
Fragmentation is often achieved by inducing ion-molecule collisions by a process 
called collision induced dissociation (CID) sometimes also called collision activated 
dissociation (CAD). CID is accomplished by selecting an ion of interest with the 
first mass analyser, and introducing the ion to a collision cell. The cell is filled with 
an inert gas, typically argon, to a known pressure, and the selected ion collides with 
the gas atoms, resulting in fragmentation. The fragment ions are then analysed in a 
second mass analyser. 
One of the most commonly used tandem mass spectrometers is the triple quad mass 
spectrometer, which as the name suggests has three quadrupoles, the first and third as 
mass analysers and the second/middle quadrupole is used as the collision cell. 
Another common tandem mass spectrometer is the quadrupole- time of flight mass 
spectrometer. This is similar to the triple quad, however replaces the third 
quadrupole with a ToF mass analyser. 
MS/MS can be performed on other instruments as well as tandem mass 
spectrometers, such as FT-ICR MS and quadrupole ion traps. The application of 
MS/MS has become widespread in the field of proteomics, and is routinely used to 
sequence peptides and protein digests. On a Q-ToF mass spectrometer it takes 
approximately 20-45 V to break the amide bond of a linear peptide (31, 32) and up to 
150 V to dissociate protein complexes (33, 34). 
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Figure 1.14 Tandem mass spectrometers. 	Top - triple quadrupole mass 
spectrometer. Bottom - quadrupole time of flight mass spectrometer (35). 
1.2 Non covalent complexes 
As stated previously, many proteins function as multimers, either with themselves, or 
with other proteins. These interactions are often referred to as non covalent 
interactions and are mainly ionic (electrostatic), hydrophobic effects and hydrogen 
bonds, along with forces such as Van der Waals forces. They do not involve a 
covalent linkage, and are often, though not always, reversible. 
For instance the inducible form of nitric oxide synthase forms such a strong 
interaction with calmodulin that the association can be considered permanent (36, 
37). Some protein complexes utilise only one form of bonding such as the ionic 
interaction of divalent calcium ions interacting with acidic side chains in the EF hand 
of calmodulin (38). However many protein complexes employ many types of 
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interaction, for instance electrostatic, hydrogen bonding and nonpolar stacking 
interactions are all involved in the binding of acyl coenzyme A binding protein (39). 
The study of protein interactions has expanded rapidly over the last ten years. 
Several diseases such as Alzheimer's and Creuzfeldt-Jacob's are associated with the 
formation of large polydisperse oligomers of ctB-crystallin (40). Research into these 
and other protein associations can help further understanding of biological processes 
and disease. 
1.2.1 Non covalent interactions analysis by traditional techniques 
Many techniques have been used to investigate non covalent interactions and the best 
information can be gained by utilising a variety of complimentary techniques to build 
up an overall picture 
NMR and crystallography are the methods of choice and unsurpassed at providing 
high resolution information on structure. These structure-based methods can provide 
information on binding sites, interactions, water molecules, orientation and a wealth 
of other information. However, there are disadvantages to both these techniques. 
Both require substantial amounts of protein at high concentration and take a long 
time to acquire data. X-ray crystallography requires crystals of sufficient size and 
quality which are often difficult to grow. The crystalline nature of the structure can 
provide dimer and multimer aggregations that do not exist in nature (41). NMR 
requires special solvents and may require the proteins to be isotopically enriched 
which can be expensive. Both techniques also solve 'average' structures, and 
provide no information on transient conformations of less than about a second or 
information on different populations that may exist. 
Spectroscopic methods such as fluorescence, circular dichroism, infrared 
spectroscopy and light scattering are often used to study macromolecular interactions 
and can provide 'real time' information. Circular dichroism is commonly used to 
provide information on secondary structure such as cc-helix and p3-sheet. 
Modern analytical ultracentrifugation can be used to determine molecular mass, 
shape and equilibrium constants. In 1926 the Nobel Prize was awarded to Theodor 
Svedberg of Uppsala University, Sweden, for development of analytical 
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ultracentrifugation (5). In the same year, this technique was used to determine the 
assembly of haemoglobin as a 66.8 kDa. tetramer from 16.7 kDa. monomers (42). 
Other techniques that can be exploited are surface plasmon resonance (42), 
proteolytic footprinting, Raman spectroscopy, atomic absorption, calorimetry, gel 
permeation chromatography, flow dialysis, rapid density measurement, electron 
paramagnetic resonance (43) and mass spectrometry. 
Recently mass spectrometry has become one of the most utilised tools in proteomics, 
to study primary structure and post translational modifications. However it can also 
provide information on non covalent interactions of proteins. 
1.2.2 Analysis of non covalent interactions by mass spectrometry 
1.2.2.1 Advantages compared to other techniques 
The use of mass spectrometry to observe and analyse protein complexes has 
expanded rapidly in the last ten years. This is due to its many advantages such as 
specificity, sensitivity, speed and the ability to elucidate stoichiometry. 
Compared to other techniques such as NMR and X-ray crystallography, mass 
spectrometry is very fast and can be performed on a very small amount of sample. 
Low picomolar to femtomolar sensitivity has been achieved on both FT-ICR (44) 
and ToF instruments (45). These experiments can be carried out very quickly. 
Specificity is a crucial advantage of mass spectrometry. A major use is in the 
screening of libraries of potential ligands, such as the work of Cheng et al, where a 
289 component library of benzenesulfonamide based inhibitors was studied with zinc 
loaded carbonic anhydrase by detecting noncovalently bound complexes (46). 
Competitive binding studies can easily be carried out as the ligand with the greatest 
intensity, and hence affinity can be distinguished by mass. 
Mass spectrometry also supplies important information on stoichiometry, especially 
in systems in which there may be heterogeneity in the stoichiometry of the complex. 
This is particularly relevant in metal binding proteins such as calmodulin, where 
binding of 4 calcium ions results in a structural change which allows subsequent 
substrate binding (47). Information on protein quaternary structure can also be 
determined by ESIMS. 
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Mass spectrometry also has some disadvantages. The most important of these is 
intolerance of involatile salts. This is normally overcome by substituting buffer salts 
for involatile buffers such as ammonium formate or acetate. However marine 
proteins and membrane proteins cannot so far be analysed as they are insoluble in 
mass spectrometric compatible solvents. Mass spectrometry also consumes the 
sample, however this in not normally a problem as very small amounts of sample are 
required. 
1.2.2.2 Conditions 
The key to observing non covalent interactions is the preservation of tertiary 
structure. The native structure of protein is commonly destroyed while in solution 
prior to analysis or during the ESI process. Optimal mass spectrometry conditions 
are not generally tolerated when trying to maintain tertiary structure and non 






Non denaturing ionisation 
conditions 
pH2-4 pH8—lO pH6-8 
adjusted by formic or adjusted by ammonia buffer controlled. 
acetic acid solution 
water:methanol or water:methanol or Volatile aqueous 
water: acetonitrile water:acetonitrile buffer 
Figure 1.15. Table detailing common conditions for ionisation (42, 48). 
To maintain native protein structure and hence complexes, volatile buffers such as 
ammonium acetate, ammonium formate and ammonium bicarbonate are commonly 
used (48). These do not often form adducts with macromolecules, unlike phosphate 
and sulfate based buffers. Typically buffer concentration is in the range of 2 - 50 
mM, although concentrations of up to 500 mM ammonium acetate have been 
required to maintain a folded structure (49). 
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Initially quadrupole mass analysers were used to detect non covalent complexes, 
however a wide range of mass spectrometers have now successfully detected 
complexes, including magnetic sector instruments, ion traps, FT-ICR systems and 
time of flight (T0F) analysers (42). Systems with a wide mlz range are commonly 
used as non covalent complexes tend to have low charge states and hence are 
observed at high m/z. Most commercial quadrupole instruments are limited to m/z 
range of 4000, however as previously mentioned some groups have extended their 
mass range to 32000 m/z to expand the number of biological systems they can study 
(21). 
Various different electrospray interfaces have been employed to analyse non 
covalent complexes including differentially pumped nozzle-skimmer interface, 
heated metal and glass capillaries inlets with or without countercurrent bath gas (42). 
Careful control of the various instrumental setting is required to maintain complexes. 
Conditions that promote sufficient desolvation are required otherwise very broad 
peaks ensue. Formation of solvent adducts greatly reduces sensitivity because the 
observable ion current is distributed over heterogeneously solvated molecular 
species. However care must be taken to not create too harsh conditions which may 
disrupt the macromolecular complex of interest. 
In an ESI source several factors contribute to the desolvation of the ion, including a 
gas flow perpendicular to the spray of multiply charged ions, and heat, either applied 
to the gas or a heated metal or glass capillary. Gas phase collisions in the low 
vacuum region also help to remove solvent molecules from the ion. 
Non covalent complexes in general will easily dissociate in the gas phase by 
vigorous desolvation with the application of excess heat, or collision energy in the 
atmospheric pressure/vacuum region. Therefore low temperatures and source 
voltages are often utilised. 
Pressure can also have an influence on retention of structure and complexes. Several 
reports have shown that increased pressures in the first vacuum stages of the mass 
spectrometer can aid the transmission of high mass ions (2], 50). Raising vacuum 
pressure in the collision cell of a Q-T0F mass spectrometer, aids in the detection of 
complexes particularly large complexes. Whether this is due to a collision focussing 
effect or more efficient desolvation is unresolved (48). 
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Nevertheless, a wide range of smaller complexes have been analysed in instruments 
which have not had these modifications (40). 
1.2.2.3 Relevance to solution 
A crucial factor in study of non covalent interactions by mass spectrometry is 
whether results in the gas phase can be extrapolated to solution phase interactions. 
Initial studies employing mass spectrometry to investigate non covalent protein 
ligand interactions retained from the solution phase into the gas phase gave rise to 
conflicting results. Aplin et al reported that complexes of porcine pancreatic elastase 
and peptide observed by ESIMS did not always fully reflect structurally specific 
interactions in solution (51). Several groups have investigated the structure of the 
gas phase molecule and related it to solution phase structure. McLafferty and co-
workers used hydrogen deuterium exchange to examine gas phase structures of 
cytochrome c, which is known to have 4 solution phase conformers. This correlated 
well with the numbers of hydrogen exchange seen by McLafferty and co-workers 
(52). Williams and co-workers also observed multiple conformations of lysozyme 
ions in vacuo. These conformations were kinetically stable and their reactivity 
suggested the possibility of distinct folding intermediates in the gas phase (53). 
Some structural elements can be preserved upon transfer from the solution phase to 
the gas phase. For instance, Loo and co-workers studied the collisionally activated 
dissociation of a small cyclic polypeptide. The naturally occurring peptide consisted 
of a chain like tail structure that inserts into a 7 residue loop. Comparison of the 
natural peptide with a synthetic version, which had the tail external to the loop, 
showed considerably different fragmentation patterns which were consistent with 
their respective solution phase structures (48). 
Subsequent studies have found that the nature of the interactions contributes to the 
retention into the gas phase. If the dominant interactions are electrostatic, greater gas 
phase stability of the complex is observed than for hydrophobically driven ligand 
binding (54). However, where the ligand is buried in the interior of a protein and the 
hydrophobic interactions are shielded in the complex, the hydrophobic interactions 
have been found to be as important as electrostatic ones (55). In large multiprotein 
complexes, much greater numbers of interactions are involved and both hydrophobic 
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and electrostatic interactions contribute and therefore the net effect is a closer 
agreement between gas and solution phase data (54). 
1.2.3 Previously studied systems by mass spectrometry 
The first reported analysis of a non covalent complex by mass spectrometry was 
from Ganem et al in 1991 (56). This communication reported the detection of a 
receptor-ligand complex by ion-spray mass spectrometry. Ion spray, sometimes 
called pneumatically assisted electrospray, in contrast to electrospray can be 
performed from water or aqueous buffer without a cosolvent. Ganem et al reported 
the complexation of FK binding protein, MWt 11812 Da, and FK506, MWt 804 to 
form a complex of 12616 Da. 
In the same year Katta and Chait (57) reported the use of electrospray ionisation to 
detect the heme - globin complex in native myoglobin. 
Since these first reports, many other complexes have been detected by mass 
spectrometry. There are increasing numbers of published results than can be 
mentioned here, but a few examples are given to highlight the variety of interactions. 
More information on the types of interactions studied can be found in the reviews by 
Timothy Veenstra (58) and Joseph Loo (42, 48) and several by Carol Robinson (59-
61). 
1.2.3.1 Macromolecular multimers 
Many large complexes have been studied by mass spectrometry, particularly 
multimers of proteins. Mass spectrometry can help define the stoichiometry of 
multiprotein complexes for which controversy exists, for instance proclavaminate 
amidino hydrolase from Streptomyces clavuuligerus was initially reported as an 
octomer, but has since been shown to be hexameric by MS and subsequently 
confirmed by X-ray crystallography. Some of the largest complexes analysed have 
been by the group of Carol Robinson who have retained and analysed ribosomes by 
electrospray mass spectrometry (59, 62). The ribosome dissociated into 30S and SOS 
subunits. The mass of the 30S subunit was theoretically calculated from the 
elemental formula of the 21 proteins and 16S RNA molecule to be 846,681 Da, 
which is 5,506 Da less than the mass observed by MS. This was attributed to the 
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trapping of water and other counterions at the large intermolecular interfaces (62). 
More recent studies have probed the structure of ribsomes further. Mass 
spectrometry was used to examine the composition of the stalk proteins on ribosomes 
from Saccharomyces cerevisiae, revealing a non covalent complex of 77 kDa. 
assigned to the pentameric stalk (59). 
1.2.3.2 Protein metal ion 
Many systems of metals interacting with proteins have been studied by mass 
spectrometry as stoichiometry can easily be investigated. Most studies are of 
biologically essential metals such as copper, zinc, iron, magnesium and calcium, 
however other metals such as mercury and cadmium have also been studied. For 
example Amster and co-workers have reported the use of an electrospray time of 
flight mass spectrometer to study the iron binding properties of rubrerythrin type 
proteins, the metals effect on protein-protein interactions and the metal oxidation 
state (63). Sadler and co-workers used ESI FT-ICR and Zn isotopes to confirm that 
one of the zinc binding sites of the cyanobacterial metaithionein SmtA was inert to 
exchange (64). 
1.2.3.3 Nucleic acid complexes 
Oligonucleotides and oligonucleotide drug complexes have likewise been studied by 
ESIMS. Double stranded DNA is stable in the gas phase and non covalent 
complexes formed between various drug molecules and oligonucleotide, both 
intercalators and minor groove binders have been reported. Both these types of 
interaction have been reported by Gabelica et al (65, 66) in which anti-tumour drugs 
were bound to a double stranded oligonucleotide. The mass spectra suggested non 
specific binding for the intercalators and specific binding for the minor groove 
binders. 
1.2.3.4 Binding constant effects 
Mass spectrometry can unambiguously determine the stoichiometry of complexes 
and has been used to investigate the stoichiometry of many protein interactions. 
However Jorgenson, Roepstorff and Heck have reported direct determination of 
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solution binding constants of bacterial cell wall peptide analogues and vancomycin 
group antibiotics from mass spectra (67). In theory the response factors for the 
complex and the free protein are similar. Measuring the relative intensities of the 
free and complexed protein and knowing the initial concentrations of protein and 
ligand, the association constant can be calculated. 
Trepanier (68) calculated the relative binding affinity of FK binding protein (FKBP) 
and two ligands FK506 and Cyclosporin A (C5A) by measuring the signal ratio of 
(FKBP:drug) 7 I (FKBP). The technique clearly distinguished between high 
affinity binding of FKBP:FK506 and the low affinity binding of FKBP:CsA. The 
observed in vacuo binding affinities were compared to reported in vitro 
immunosuppressive activities obtained using mixed lymphocyte culture assays and 
the results were comparible. Association constants determined in this way between 
short oligonucleotide duplexes and small organic ligands correlate well with those 
determined by fluorescence titration (65). 
Other studies however have not found correlations between binding constants 
calculated in the gas phase and those in the solutions phase. In a study of avoparcin 
and bacterial receptor mimicking peptides the order of gas-phase stabilities of the 
non covalent complexes is different from the same complexes in solution (69). 
The majority of the systems discussed here have been ionised by electrospray 
ionisation, however other ionisation techniques, such have MALDI have been 
reported for studying noncovalent interactions (70). For a good early review and a 
list of many the systems studied see "Studying noncovalent protein complexes by 
electrospray ionisation mass spectrometry" by Joseph Loo(42). 
In this work two systems of non covalent interaction are studied: Cyclophilin and its 
formation with peptides and synthetic ligands; and Calmodulin and its ability to bind 
divalent cations and subsequently protein and peptides. 
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1.3 Cyclophilin A 
1.3.1 Immunophilins 
Immunophilins are an important group of proteins that are involved in a variety of 
processes in the body (71). The family is divided into three subsets, Cyclophilins, 
FK506-Binding Proteins (FKBP) and Paravulins. Cyclophilins selectively bind the 
immunosuppressant drug Cyclosporin A (72), whilst FKBPs selectively bind the 
drugs FK506 and rapamycin (73). Paravulins are inhibited by juglone, however in 
contrast to CsA and FK506, inhibition by juglone is irreversible (73). 
Immunophilins are also known as peptidyl-prolyl cis-trans isomerases (PPIase) due 
to their ability to catalyse the interconversion of the cis and trans isomers of the 
peptidyl-prolyl bonds in peptides and proteins. 
Protein folding was originally thought to be spontaneous, and all information 
required for proper folding was contained in the primary amino acid sequence. A 
rate limiting step however is the cis-trans isomerisation of peptidyl-prolyl bonds, 
which unlike most peptidyl bonds can exist as either cis or trans conformations. The 
first PPJase was discovered in 1984 by Fischer et a! (74). In the same year, the 
search for the intracellular receptor of Cyclosporin A (CsA) was discovered and 
named cyclophilin. In 1989 it was demonstrated that cyclophilins and PPlases were 
species variants of the same protein. However the PPIase activity of these proteins is 
not essential for immunosuppressive effects. 
1.3.2 Activity 
The two most important functional properties of cyclophilins are their PPIase activity 
and their ability to bind CsA. However cyclophilin A (CypA) is involved with anti 
human immunedeficiency virus (HIV) replication (75) and has recently been shown 
to bind to severe acute respiratory syndrome (SARS) coronavirus (76). 
1.3.2.1 Immunosuppressant activity 
The immunosuppressive activity of CsA requires formation of a complex with 
Cyclophilin A. 
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Figure 1.16 schematic of the mechanism of immunosupression (77). 
Figure 1.16 shows the mechanism of immunosupression. T cell activation causes 
rejection of a graft organ after transplant. To activate T cells, calmodulin (CaM) 
must bind to calcineurin (CN). This binding is activated by high levels of free 
calcium in the cell. The CaM:CN complex dephosphorylates the nuclear factor of 
activated T cells (NF-AT), which is then able to cross the nuclear membrane. The 
NF-AT regulates the transcription rates of Interleukin- 1. The CypA:CsA complex 
stops this process by binding to CN and blocks the dephosphorylation of NF-AT and 
hence its ability to cross the nuclear membrane. CypA or CsA alone will not inhibit 
this process, the complex of CypA:CsA is required. 
The FKBP:FK506 complex can inhibit the phosphatase activity of CN in a similar 
fashion. This mechanism of immuno suppression is independent of the PPIase 
activity of the immunophilins. 
1.3.2.2 HIV replication activity 
Cyclophilin A has also been reported to bind to human immunodeficiency virus type 
1 (HIV) gag protein (78). The CypA binds within the viral core of the HIV-1 protein 
and is necessary for the release of viral RNA and hence multiplication of the virus. 
Inhibition of CypA using CsA prevents incorporation of the CypA into the HIV 
protein and reduces viral proliferation. 
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1.3.2.3 Anti parasitic activity 
Cyclosporin has been reported to have widespread anti-parasitic effects that have 
been described both in vitro and in vivo. The anti-parastic activity has stage specific 
effects against a number of parasitic nematodes (79) which include associated 
tegumental and gut structural damage. 
1.3.3 Physical properties of cyclophilin A 
Cyclophilins are highly conserved between species and are found in fungi, plants 
bacteria, and vertebrates. There are at least 8 different forms of human cyclophilins 
ranging from 18 kDa to 150 kDa. Human cyclophilin A binds cyclosporin A in 
nanomolar concentrations (80) and Kd =30nM (81). Human cyclophilin A is a single 
polypeptide chain containing 164 amino acid residues (figure 1.17) and it has an 
isoelectric point value of 7.8 (82). Its molecular weight calculated from its primary 
sequence is 17881 Da. The crystal structure solved by X-ray crystallography 
showed (figure 1.18) the main structural feature to be an eight stranded anti-parallel 
barrel (83). The $3 barrel core is tightly packed with hydrophobic residues. It is to 
the outside of this barrel that cyclosporin is thought to bind (83). 
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Figure 1.17 Sequence of Human Cyclophilin A in one letter amino acid code. 
Residues in red are acidic, in blue basic 
3 barrel core 
a helix 
Figure 1.18 	X-ray crystallography structure of human cyclophilin A (83) 
1.3.4 Physical properties of cyclosporin A 
Cyclosporin A is a cyclic undecapeptide produced by produced by the ascomycete 
fungus Beauveria five. Cyclosporin A was discovered in 1970 in a Norwegian soil 
fungus by Jean F. Borel at Sandoz laboratories and it was approved for use in 1983 
(84). The chemical name of cyclosporin A is [R-[RR-(E)]J-cyclic(L-alany1-D-
alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy- 	N,4- 
dimethyl-L-2-amino-6-octenoyl-L-a-amino-butyryl-N-methyl glycyl-N-methyl-L- 
leucyl-L-valyl-N-methyl-L-leucyl) and the empirical formula is C 62 I-I l 1N 1 012 
(1202.6303 amu). It is found widely distributed in nature in organisms ranging from 
prokaryotic to eukaryotic organisms (85). Its immunosuppressive properties were 
first reported in 1978. The chemical structure of cyclosporin A is shown below in 
figure 1.19 and the region involved in binding to cyclophilin A is highlighted in red. 
Figure 1.20 also shows the 3 letter amino acid code for cyclosporin where the prefix 
Me indicated N-methylation and the uncommon amino acids in positions I and 2 are 
(4R)-4-((E)-2-butenyl )-4, N-dimethyl-L-threonine and L-c-aminobutyric acid 
respectively. 
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Figure 1.19 Structure of cyclosponn A 
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Figure 1.20 Residues of CsA in three letter code. 
The structure of CsA bound to CypA is radically different to that of unbound CsA. 
When bound the side chains are flipped from the inside to the outside (83). 









Figure 1.21 	X ray crystallography structures of CypA:CsA from two different 
observation angles. 
Figure 1.21 shows two views of the crystal structure of cyclosporin bound to 
cyclophilin, the structure on the left is comparable with the unbound cyclophulin 
structure shown in figure 1.18 previously and the structure on the right rotated to 
show the peptide in the binding "cleft". The cyclic peptide binds to the outside of the 
B barrel. 
Cyclosporin binds to Cyclophilin A through residues 9,10,11,12 and 3 (86) of the 
ligand. There are five direct hydrogen bonds between CypA and CsA and five water 
molecules mediating intermolecular interactions. Residues 4,5,6,7 and 8 do not 
interact with CypA and protrude out from the CypA:CsA complex surface and hence 
are implicated in specific interactions with Calcineurin (CN) (85, 87). 




1.4.1 Calcium binding proteins 
Calcium is plentiful in biological systems, mainly complexed with phosphates to 
form exo- or endoskeletons, however the human body utilises a small amount of 
calcium in the form of calcium ions in essential roles such as cell signalling, control 
processes, nerve signalling, fertilisation, and cell division. 
The fluctuations in Ca2 concentration is deciphered by various intracellular Ca 2+  
binding proteins. Some of these proteins such as protein kinase C, bind to Ca 2+  and 
are directly regulated in a Ca 2+ 2+ dependent manner. Other Ca binding proteins are 
intermediaries that couple Ca 2+  signals to the biochemical and cellular changes. 
These proteins respond to Ca 2+  in one of two ways. 
Proteins such as parvalbumin and calbindin, which do not undergo a 
significant change in conformation upon binding Ca 2+  and act as Ca 2+ buffers 
,- 2+ or ua transporters. 
Proteins such as Troponin C and Calmodulin which undergo a Ca 2+  change 
in conformation. 
Of these, Calmodulin is the most extensively studied. It is expressed in all 
eukaryotic cells where it participates in signalling pathways that regulate many 
crucial processes such as growth, proliferation and movement. Its function and 
structure has been intensely investigated and it is mostly widely noted for the major 
conformational change that occurs upon binding calcium ions, which is discussed 
later in this chapter. However, it has principally been examined as it has such a wide 
variety of activities in the body. 
1.4.2 Activity 
CaM interacts with an impressive number of proteins, with a wide physiological 
diversity (88), which have a broad biological role in the body. CaM binding proteins 
can be (roughly) categorized into 6 groups (89). 
1. Proteins which bind irreversibly to CaM irrespective of Ca 2t An example is 
phosphorylase kinase, an enzyme which requires denaturing conditions to 
dissociate CaM but is activated in the presence of Ca 2t 
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Proteins which bind to apo CaM but dissociate reversibly in the presence of 
Ca2 . Examples of this group are neuromodulin, and neurogranin which 
might serve as intercellular reservoirs for CaM at resting concentrations of 
Ca2 , but liberate Ca 2 activated CaM in response to elevated Ca 2 . 
Proteins which form low affinity, inactive complexes with CaM at low 
concentrations of Ca 2 , when the Ca2 sites of CaM are empty or partially 
occupied. At greater concentrations of Ca 2+  these proteins engage in high 
affinity complexes with and are activated by CaM. Calcineurin and smooth 
muscle light chain kinase (MLCK) belong to this group. 
Proteins which bind to CaM in the presence of Ca 2 , but CaM inhibits their 
function. This group includes enzymes such as select members of the G 
protein receptor kinases and well as the inositol (1,4,5) trisphophate receptor 
type 1. 
Proteins that exhibit a more conventional behaviour and are activated by 
CaM- Ca2 , such as CaM dependant protein kinases I, II and IV. 
Proteins in which CaM binding promotes their regulation, for instance 
multimeric CaM kinase II, both the substrate and the catalytic subunits 
require CaM binding to promote intermolecular autophosphorylation. 
The list of CaM targets is long, and therefore only CaM activity in relation to protein 
targets used in this work are discussed further. 
1.4.2.1 Cell proliferation and growth 
Since Ca2 is essential for progression through GUS and mitosis, CaM is believed to 
perform a crucial role as an intercellular receptor which regulates cell proliferation 
and growth. Diseases characterised by unregulated cell growth, for instance cancer 
and psoriasis, have been shown to have elevated levels of Ca 2 CaM. The role of 
CaM can be inhibited by a number of pharmacological agents of such as 
antipsychotics, muscle relaxants, antidepressants, minor tranquilisers and local 
anaesthetics (90). Phenothiazines were the first class of drugs to exhibit this 
property, of which trifluoroperazine (TFP) is the strongest inhibitor (91). Other 
inhibitors are endogenous peptides such as neuropeptides and insect venoms such as 
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honey bee venom, melittin. Due to their inhibitive properties, CaM antagonists such 
as TFP have been evaluated for the treatment of cancers and have been shown to be 
both sensitive and resistant to conventional anti cancer drugs (90). 
1.4.2.2 Nitric oxide synthesis 
The enzyme nitric oxide synthase (NOS) (92) is a calmodulin activated enzyme 
which exists in three isoforms. Two of these isoforms, neuronal NOS (nNOS) and 
endothelial NOS (eNOS), bind calmodulin reversibly, but calmodulin binds 
irreversibly in the inducible NOS (iNOS) isoform (36). Mammalian NOS is 
responsible for generating nitric oxide in a wide range of cell types. NOS's are 
homodimeric and consist of a reductase domain, which binds flavin adenine 
dinucleotide (FAD) and flavin mononucleotide (FMN) stoichiometrically, and an 
oxygenase domain, which contains a cytochrome P450 like cys ligated heme and a 
tetrahydrobiopterin molecule. The main dimer interface is through the oxygen 
domain, and the tetrahydrobiopterin is a vital component of this. The two domains 
are linked by a functional peptide loop of 20-25 residues which binds calmodulin at 
raised calcium levels. CaM binding has been shown to control NO synthesis by 
activating electron transfer through the enzyme (93). 
Crystal structures are available for several NOS oxygenase domain dimers (94, 95), 
and for the FAD binding domain of nNOS (96), however the structure of the full 
homodimer, with calmodulin and other associated ligands has yet to be solved. 
1.4.2.3 Immunosupression. 
As detailed in section 1.3.2.1, and figure 1.16, calmodulin is involved in suppression 
of the immune system. To activate T cells, holo calmodulin must bind to calcineurin 
(CN). The CaM:CN complex dephosphorylates the nuclear factor of activated T 
cells (NF-AT), which is then able to cross the nuclear membrane (77). 
1.4.2.4 CaM and myosin light chain kinase 
Although not directly here, the interaction of calmodulin with smooth muscle myosin 
light chain kinase (5mMLCK) and skeletal MLCK (5kMLCK) has been widely 
reported (97, 98) due in part to the ease of obtaining sufficient quantities of protein. 
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MLCK is calmodulin dependant and is used in the cell for contractility and motility 
(99). Peptides derived from the MLCK have been shown to induce the same 
structure in CaM as the whole protein (100. 101). The interaction between the 
strongly negative protein and highly positively charged peptide has been described as 
mainly electrostatic, and it has been noted that the protein releases a number of 
protons when binding the positively charged peptide (101). The binding of the 
peptide to calmodulin is surprisingly insensitive to the net charges of both the peptide 
and the protein, and it appears that the net charge of both change during the binding 
process. 
Although MLCK can bind to apo CaM (88) for many enzymes it is normally calcium 
saturated calniodulin that is the active form. Calmodulin is unusually abundant in 
methionines and non polar amino acids. This hydrophobic region is exposed when 
calmodulin undergoes its calcium induced structural change, and is commonly 
involved in the binding of calmodulin to target sites on other peptides and proteins. 
1.4.3 Physical properties and structure 
Human calmodulin is a 148 amino acid peptide, the sequence of which is shown in 
figure 1.22. It has 38 acidic side chains and 1 5 basic, reflecting its low isoelectric 
point of 3.9 (102). 
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Figure 1.22 Sequence of calmodulin in one letter amino acid code. 	Residues in 
red are acidic, in blue basic. 
The structure of calmodulin has been widely studied, and although a crystal structure 
of apo CaM is yet to be solved, the structure of this form was solved by NMR in 
1995 (103). Apo calmodulin is comprised of two globular domains connected by a 







Figure 1.23 A) NMR structure of apo CaM (103). B) X-ray crystallography 
structure of holo CaM (104). 
Each domain consists of two helix - loop - helix Ca 2 ' binding regions referred to as 
EF hand structures (90), the calcium binding ability of which is discussed in section 
1.4.3. Upon exposure to calcium, calmodulin undergoes a major structural change, 
the two anti parallel helices in each EF hand of apo CaM become perpendicular. The 
resultant movement of the Ca 2+  binding loops may cause the domains to become 
more rigid and less solvent accessible. A central linker region, in the form of a helix 
is also exposed. The x-ray crystallography structure of holo calmodulin is shown in 
figure 1.2213 Most native crystal structures of CaM Ca resemble the first structure 
solved in 1985 (105). However, recently a closed compact structure of native Ca 2+  
CaM has been published (106). 
Calmodulin has four EF hands, and each binds a single calcium ion. A schematic of 
calcium binding to calmodulin is shown in figure 1.24 (38) the EF hands of which 
are numbered I - IV from the N terminus. 
Figure 1.24 An outline of the domains of CaM. Each circle represents an amino 
acid residue. Circles in bold are helical stretches. Inset shows EF 
hand I and the interactions between CaM and Ca 21  
The structural change that occurs when calcium binds to calmodulin exposes a 
helical linker between the N and C domains, which is rich in methionines and other 
non polar residues. It is to this central flexible helix of holo calmodulin that many 
target proteins discussed in section 1.4.2, bind. The structure of calmodulin bound to 
its target protein is again different from the apo and holo forms of calmodulin, as 
shown in figure 1.25. The two structures on the left show calmodulin bound to two 
different target enzymes: myosin light chain kinase (2bmm) at the top and 
endothelial nitric oxide synthase peptide bound to calmodulin at the bottom. In both 
cases, only a small piece of the target protein chain (shown in yellow) is included in 
the crystal structure. The flexible linker helix of calmodulin allows the protein to 
conform to the different sequences of these two targets by "clamping" around the 










Figure  1 .25 	X-ray crystallography figures of CaM interacting with 3 different 
ligands (in yellow). A) CaM and MLCK peptide. B) CaM and eNOS 
peptide. C) CaM and edema factor toxin from antahrax. Each CaM 
conformation is different. 
This type of interaction is common in CaM dependent serine/threonjne kinases such 
as myosin light chain kinases. Previous studies (89) have shown that CaM can adopt 
three different conformations by virtue of the flexible linker peptide, and that the 
interactions all involved short helices (of approximately 20 residues) formed by the 
binding domain of the kinase. For CaM dependent serine/threonjne kinases' 
substrate family, defined CaM binding motifs currently fall into three groups, 1-10, 
1-14 and 1-16, which are distinguished by their spacing of bulky hydrophobic and 
basic amino acids and are bracketed by aromatic residues near either end. Another 
helical CaM binding motif is the so called IQ motif, which corresponds to an 
IQxxxRGxxxR consensus sequence which is known to appear in tandem repeats and 
to bind multiple CaM molecules in a predominantly Ca independent manner. It 
appears that these canonical recognition motifs are used by many CaM dependant 
proteins, such as calcineurin, nitric oxide synthases, 1P3 receptors, plasma membrane 
calcium ion pumps, ras guanine nucleotide exchange factor, RAS-GRF, and 
rhodopsin protein phosphatase. Nevertheless, CaM interacting proteins cannot 
always be identified by sequence analysis based on these binding criteria, and 
equally proteins that bind to CaM sometimes do not fit these recruitment motifs. 
A different binding geometry is seen in the edema factor toxin from the anthrax 
bacteria (pdb 103), shown here on the right figure 1.25C. (108) Once the 
calmodulin is bound to the toxin, shown in yellow, a conformational change activates 
its adenylyl cyclase activity, which then depletes the host cell's energy stores. Since 
calmodulin is absent in bacteria, the anthrax bacteria have evolved to utilise the 
calmodulin in the host in order to trigger the toxin and take control of their cellular 
machinery (88). 
1.4.4 EF hands 
EF hands are found in many calcium binding proteins such as troponin C and 
calmodulin, and are called EF hands because of the perpendicular nature of the 
helices on either side of the ca2+ binding loop which form a shape similar to an 
extended thumb and forefinger of a hand. Figure 1.26 shows the typical structure of 
EF hands I and II from the N terminal domain of calmodulin. 
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Figure 1.26 EH hand shape of CaM EF hands land II around Ca 2+  ions 
Calcium is a bidentate ligand and will bind to negative charges that are normally 
supplied from aspartic acid and glutamic acid side chains. It can form several 
coordination geometries, however in the EF hand it favors a 7 coordination 
geometry. The main interactions for two EF hands from CaM are shown in figure 
1.27. The red residues are acidic side chains and the green are polar residues such as 
threonine. The coordination geometry of the EF hands is discussed further in section 
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Figure 1.27 	EF hands I and 11 of CaM indicating residues involved in the EF 
hands residues in red are acidic, in green are polar. 
The calcium binding sites were predicted from the primary sequence (109) and the 
binding of calcium ions to calmodulin and particularly the EF hands has been 
extensively studied and reported by a variety of methods including X-ray 
crystallography, NMR, fluorescence, proteol ytic footpri nting, circular dicroism, UV, 
atomic absorption. Raman spectroscopy, infrared spectroscopy, calorimetry, gel 
permeation chromatography, ultracentri fugation, flow dialysis, rapid-density 
measurement, Ca potential measurement, electron paramagnetic resonance, and mass 
spectrometry. These methods have established that 4 calcium ions bind specifically 
to EF hands of calmodulin, and some have been employed to determine that the 
affinity is in the range I x 106 - I x iO M'. A degree of primary sequence 
homology is seen between the EF hands of calmodulin. 
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D K D G D G T I T T K E loop I N terminus 
D A D G N G T I D F P E loop II N terminus 
D K D G N G Y I S A A E loop III C terminus 
D I D G D G Q V N Y E E loop IV C terminus 
Figure 1.28 sequence of EF hands I - IV 
The positions marked in boldface in figure 1.28 correspond to sites of calcium 
ligatation (110). These residues bind to the calcium via side chain carboxylate, 
alcohol, or carboxamide oxygens or via the backbone carbonyl groups. 
1.4.5 Calcium binding cooperativity 
Controversy about the sequence of calcium ion binding, and co-operativity between 
the calciums exists and numerous studies have been carried out to probe the 
mechanism of calcium binding to calmodulin. There are three groups of models 
(111). 
four independent and equivalent sites 
four independent sites but two affinity classes - ie two pairs of independent 
sites 
cooperative binding among the sites 
The first model is in agreement with experimental data obtained by direct binding 
studies and is quite simplistic. The second model is based on early NMR and other 
spectroscopy studies, titrating in calcium and monitoring the spectral changes. The 
third model is the most widely supported and suggests a coupling between the four 
sites, with either positive or negative co-operativity. 
The third binding model involving co-operativity between the calcium binding sites 
can be further subdivided into two (111). 
the two sites of a given lobe of calmodulin exhibit positive cooperativity and 
that the C terminal pair have a greater affinity for calcium than the N terminal 
pair, and that there is no coupling between the C and N terminus lobes 
there is coupling co-operativity between sites adjacent in the sequence and 
that there is coupling between the sites in the C and N terminus 
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There are variations on when the coupling between the two halves of calmodulin 
happens, Yazawa et a! (112) postulates that this happens only in the presence of a 
calmodulin binding structure. 
Although earlier studies into the sequential binding of calcium proposed the order of 
binding to be II, I, III, IV (113) (figure 1.23) it has more recently been widely 
accepted to be III, IV, I, II. (111, 114) 
Further controversy concerns secondary, sometimes called auxiliary, calcium ion 
binding sites on calmodulin (114-116). Milos et a! (116) provide evidence of four 
capital and six auxiliary cation binding sites. The auxiliary sites are further broken 
down to two subclasses with different binding affinities (114). These auxiliary sites 
are also reported to bind other cations, as are the EF hands. 
1.4.6 Divalent cations binding to CaM 
The EF hands of CaM are targeted to bind Ca 2 , however the ionic environment 
inside a cell is very complex and various metals exist, in a variety of concentrations 
and oxidation states. 
The impact of Mg 2+  on Ca 2+  binding to calmodulin is of large physiological 
relevance and has long been a matter of debate. (114, 117). Since primary protein 
targets of calcium must be able to respond in a background of 100 - 10000 fold 
excess of Mg2 , the interdependence of Mg 2 and Ca2 is an issue. 
Studies of magnesium and calmodulin show that magnesium does not cause the same 
conformational change as calcium (117) and a study by electrospray mass 
spectrometry show that there is no propensity for the CaM:4Mg conformer (55). 
Unlike calcium, which has a greater affinity for the C domain of calmodulin Mg 2+  
binds preferentially to the N domain (43). Nevertheless, several groups report that 
the binding affinity of calcium to calmodulin decreases with raised magnesium 
concentrations (43, 117, 118). This indicated either a direct competition between Mg 
and Ca in the Ca binding loop (118) or allosteric effector status for Mg 2+  (117). 
Chao et al in a preliminary study, linked the activation of CaM by various metal 
cations to the ionic radii of the ion (119). Using a variety of methods including size 
exclusion gel electrophoresis and tyrosine fluorescence spectroscopy they showed 
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that cations, both di- and trivalent, with similar radii to Ca 2 could induce a similar 
structural change. 
Other cations, such as La 3+'  Tb 3+'  Pb 2+'  Sm3+  , Sr 2+, Hg2+  , Cd 2+'  Zn 2+ 	 2+ , and Mn have 
all been shown to interact with Calmodulin (120). Some of these metals were shown 
to compete for the calcium binding sites whilst others may have effects on 
calmodulin's conformation beyond those produced by calcium alone. Mills and 
Johnson proposes that CaM has four main cation binding sites which must be 
occupied for functional interaction with a target, in their case felodipin, however a 
CaM contained a further undefined number of cation binding sites, which produce an 
allosteric conformational change in CaM, allowing the protein to bind 2 mol of 
felodipin more tightly then when the additional (auxiliary) binding sites are not 
occupied. 
Milos et a!, using microcalorimetry further defined these interactions, proposing that 
calcium and strontium have affinity for the primary sites, the EF hands, whilst zinc, 
manganese, copper and mercury bind specifically to the auxiliary sites. A third 
group, lanthanum, terbium, lead and cadmium can bind both to the capital and the 
auxiliary sites although with very different affinities. 
It is has been suggested that calmodulin may be a mediator of some of the toxic 
effects of these heavy metals (119). 
In this project the binding of a number of divalent cations, calcium, magnesium, 
strontium, cadmium and lead, to Calmodulin was probed by electrospray mass 
spectrometry. The binding of calcium and magnesium is well documented as 
described earlier. Strontium was chosen as another member of the alkali earth 
metals, which although biologically utilised in some species, has potential toxic 




The cyclophilin A used in this work was produced and purified as detailed below. 
The other proteins, were either purchased or gifted by collaborators within the 
University of Edinburgh. Details of the preparation of samples for analysis, the 
concentrations used and the mass spectrometer settings are also documented. 
2.1 Cyclophilin A production 
The cyclophilin A plasmid was gifted by Prof Malcolm Walkinshaw as transformed 
E. coil cells. Protein was overexpressed and purified as detailed below. 
2.1.1 Sterile procedures 
Equipment and media were autoclaved (121'C, 20 mm) using Monarch 745rh 
autoclave or Astell Scientific autoclave. Sterile disposable lab equipment was used 
when appropriate. Sterile procedures were performed on the bench under flame, or 
in a SterilGard Class II Type A/B3 biological safety cabinet. 
2.1.2 Reagents 
The following stock solutions and media were prepared for use in overexpression 
and purification of cyclophilin A from E. coil. 
2.1.2.1 Stock solutions 
Ampicillin - a stock solution of 100 mg/mL in autoclaved water was prepared, sterile 
filtered and stored at —20 °C. 
Buffer 1 (low salt) - 50 mM HEPES pH 6.8, 5 mM EDTA, 5 mM B-
Mercaptoethanol. 
Buffer 2 (high salt) - 50 mM HEPES pH 6.8, 5 mM EDTA, 5 mM B-
Mercaptoethanol, 1 M Sodium chloride. 
Buffer 3 (low salt) - 50 mM HEPES pH 6.8, 5 mM B-Mercaptoethanol. 
Buffer 4 (high salt) - 50 mM HEPES pH 6.8, 5 mM B-Mercaptoethanol, 1 M Sodium 
chloride. 
Dialysis Buffer - 50 mM HEPES pH 6.8, 5 mM EDTA, 5 mM B-Mercaptoethanol. 
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IPTG - a stock solution of 1 M Isopropyl , D - thiogalactopyranoside was prepared 
in autoclaved water, sterile filtered and stored at —20°C. 
Lysis buffer - 50 mM HEPES pH 6.8, 5 mM Benzamidine, 5 mM EDTA, 5 mM B-
Mercaptoethanol. 
SDS running buffer —25 mM Tris - HC1 pH 8.3, 192 mMe, l%(w/v) SDS 
SDS sample buffer - 0.5 M Tris - HC1 pH 6.8(1 mL), Glycerol (2.0 mL), 10%w/v 
SDS (1.6 mL), B-Mercaptoethanol (0.4 mL), 0.05% w/v bromophenol blue (2.0 mL). 
Coomassie Blue stain - Methanol (400 mL), Acetic acid (100 mL), Coomassie blue 
R250 (500 mg) made up to 1000 mL with de-ionised water. 
Destain - Methanol (400 mL), Acetic acid (100 mL), made up to 1000 mL with 
distilled water. 
2.1.2.2 Media 
Agar plates - 15 g per litre agar added to specified media, autoclaved, cooled to 
50°C, antibiotic stock added, and 25 mL poured into a petri dish. 
Luria Bertani (LB) broth - Typtone (10 g), yeast extract (5 g), sodium chloride (5 g), 
in 1000 mL distilled water. 
SOC Medium - Tryptone (20 g), yeast extract (5 g), sodium chloride (0.5 g) in 1000 
mL distilled water, autoclaved, and prior to use 1 M MgCl2  (10 mL), 1 M MgSO 4 (10 
mL) and 20% (w/v) glucose (20 mL) was added. 
2.1.3 Procedures 
2.1.3.1 DNA plasmid purification 
The CypA plasmid was obtained from the group of Malcolm Walkinshaw, 
University of Edinburgh in an unknown strain of Echerichia coil (E. coil). The DNA 
plasmid was purified from 10 mL bacterial culture using QlAprep Spin Miniprep kits 
(Qiagen, UK) following the supplied protocal. Purified plasmids were eluted from 
the spin columns in 10 j.tL of 10 mM Tris .HC1 buffer pH 8.5 and stored at —20°C. 
2.1.3.2 Plasmid transformation 
50 tL chemically competent cells were alloquoted in prechilled 15 mL Falcon 2059 
polypropylene tubes. 4 cell lines were used BL21, JM109, B834 and DH5a. 0.85 
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.tL of 13 - mercaptoethanol provided was added to tube giving final concentration of 
25 mM per tube. The tubes were incubated in ice for 10 minutes, whilst swirling the 
contents of the tube every 2 minutes. 1 jiL of plasmid DNA was added and the tubes 
contents gently swirled. The cells were left on ice for 30 minutes, heated at 42°C for 
45 seconds and returned to ice for 2 minutes. 0.9 ml, of preheated SOC medium 
(42°C) was added and the tubes incubated at 37°C for 1 hour with shaking at 225-
250 rpm. 200 tL of transformation mixture were streaked on LB agar plates with 
100 tg/mL ampicillin and incubated at 37°C overnight. 
2.1.3.3 Growth of E. co/i for production of cyclophilin A 
A single colony was picked from the agar plate and placed in 10 mL of LB media 
containing 100 p.g/mL of ampicillin in a 30 mL falcon tube. This was incubated at 
37°C with 250 rpm shaking overnight. This was done in duplicate and the cultures 
combined. A 200 jtL sample was retained for analysis by SDS-PAGE gel 
electrophoresis. 
8 x 250 mL of LB media, containing 100 tg/mL of ampicillin, in 8 x 1 L baffled 
flasks were inoculated with 2.5 mL of overnight culture each. The flasks were 
shaken at 37 °C and 250 rpm until 0D 600 0.6. A 200 tL sample of each flask was 
taken and combined, for analysis by SDS-PAGE gel electrophoresis. 
Flasks were then inoculated with 100 tL IPTG stock, and shaken at 37 °C and 250 
rpm for a further 3 hours. A 200 p.L sample of each flask was taken and combined, 
for analysis by SDS-PAGE gel electrosphoresis. 
The cells were harvested by centrifugation at 4 °C and 10,000 rpm for one hour in a 
Sorvall RC SC plus centrifuge. The pellets were combined and stored at —20 °C. 
2.1.3.4 SDS-PAGE analysis. 
To check cyclophilin A presence at various stages during E. coli growth, cell lysis 
and protein purification, Sodium dodecyl sulphate (SDS) polyacrylamide gel 
electrophoresis (PAGE) analysis was performed. 
Pelleted samples were resuspended in SDS running buffer, soluble protein samples 
diluted with SDS running buffer. The samples were then heated at 50 °C for 5 
minutes, cooled and centrifuged at 10,000 rpm in a MSE Micro centaur centrifuge. 
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Samples were then loaded into BioRad pre-cast 10 well 10 - 20 % Tris - HC1 
gradient acrylamide gels (BioRad, UK) and run at constant voltage of 200 V by 
Powerpac 200. The gel was then placed in a staining solution and agitated on a 
rocking platform for 30 minutes, placed in de-stain solution agitated on a rocking 
platform until the background of the gel was clear. 
2.1.3.5 Cell lysis 
The frozen biomass from growth media was thawed and resuspended in minimal 
chilled lysis buffer. The suspension was sonicated using Soniprep 150 sonicator on 
ice using an on off protocol (30 sec sonication, 30 sec off, 10 cycles). The viscous 
mixture was then centrifuged at 18,000 rpm for 50 minutes, and the clear supernatant 
stored at 4 °C. The pellet was discarded. 
2.1.3.6 FPLC protein purification 
The protein was purified by on a Amersham Pharmacia Biotech AKTA FPLC using 
cation exchange chromatography. Two procedures were carried out. The procedure 
was carried out at 4 °C. 
Purification 1 - Prior to purification by FPLC the cell free extract was dialysed 
against starting buffer 1A. The cell free extract was then filtered through a 0.45 p.m 
sterile membrane filter. Method 1 was as follows 
Column - Hi Load SP Sepharose 26/10 (bed volume 50mL) 
Low Salt Buffer - 4 °C Buffer 1A 
High Salt Buffer - 4 °C Buffer I  
Flow rate —4 mL/min 
Conditioning column - 100 mL 100% Buffer 1A 
Sample loading - approx. 40-60 mL appropriate to sample volume 
Column wash - 100 mL buffer 1 
Elution— 150 mL from 0% -50% buffer I  
25 mL hold 50% buffer I  
50 mL from 50% - 100% buffer lB 
Wash - 75 mL 100 % buffer I  
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Fraction collection - 10 mL until start of gradient 
2 mL until after 50 % buffer I  
10 mL until end 
The UV and conductivity outputs were monitored and the fractions across each peak 
sampled and analysed by SDS PAGE for purity of cyclophilin. The purest fractions 
were combined and re-purified by FPLC. 
Purification B - The combined fractions were dialysed against buffer 2A. Method 2 
is as follows. 
Column - Resource S (bed volume 6 mL) 
Low Salt Buffer - 4 °C Buffer 2A 
High Salt Buffer —4 °C Buffer 2B 
Flow rate - 1 mL/min 
Conditioning column - 12 mL 100% Buffer 1 A 
Sample loading - approx. 20-30 mL appropriate to sample volume 
Column wash - 12 mL buffer 1 
Elution - 12 mL from 0% - 10 % buffer I  
12 mL from 10% - 50 % buffer I  
6 mL from 50% - 100% buffer lB 
Wash —24 mL 100 % buffer I  
Fraction collection - 10 mL until start of gradient 
1 mL until 50% buffer 2B 
Samples were collected from each peak and analysed by SDS PAGE to check purity 




bA 	 P4 . 
Figure 2.01 SDS PAGE of CypA fractions 20 - 28 and 40-42 collected from 
cation exchange column. C is the sample loaded onto the column. M 
the molecular weight marker. CypA runs between markers 14.1 kDa 
and 20.1 kDa. 
2.2 Calmodulin 
Bovine brain calmodulin was obtained from Dr Simon DafT as lyophilised protein 
overexpressed from E. co/i, as described previously by Daff and co-workers( /21). 
Fiiure 2.02 	Sl)S-PAGE of CaM received from Daff research group. 
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The gel of CaM run with Invitrogen's SeeBlue plus2 molecular weight marker from 
4kDa to 250kDa indicates the CaM to be pure and to have a mass between Lysozyme 
1 6kDa and Myoglobin Red 22kDa. 
2.2.1 Apo calmodulin 
The metal ions were chelated from the calmodulin solution by addition of 0.4 M 
EGTA. The protein was then passed through a 10 DG column (Bio-Rad 
Laboratories, UK) and eluted with 10 mM ammonium acetate, pH 6.8. Fractions 
containing protein were pooled and concentrated by Vivaspin cartridges 
(Vivascience AG, Germany). Recovery of calmodulin from this process varied 
between 70 and 0 %. 
2.3 Ligands 
2.3.1 nNOS28 
The FMN domain of nNOS (nNOS28) was obtained from Dr Simon Daff at a 
concentration of 350 tM in 50 m Tris-HC1 pH 7.5, 0.1 M KC1, 1mM CaC12. The 
protein was overexpressed from e coli, as described previously by Daff and co-
workers(121). The protein was stored at -20 °C. The sample was defrosted and 
diluted in ultrapure water to the desired concentration prior to analysis. 
2.3.2 nNOS peptide 
The proposed CaM binding domain of nNOS was synthesised by Dr Derek 
McMillan, University of Edinburgh (122) as received as freeze dried solid. The 
sequence of the peptide is KRRAIGFKKLAEAVKFSAKLM and the C and N 
termini were functionalised as amide and N-acetyl respectively to mimic a section of 
protein within a large domain. 
Peptide was dissolved in ultrapure water at 2 mg/mL to create a stock solution of 82 




Cyclosporin A, Rapamycin and Melittin were purchased from Sigma Aldrich UK. 
Stock solutions were made to 1 mM in methanol and stored at 4 °C. Samples were 
diluted to 100 mM in 10 mM ammonium acetate prior to dilution to required 
concentration in solution. 
2.3.4 Synthetic ligands 
The library of potential inhibitors of CypA was obtained from the group of Nick 
Turner, University of Edinburgh along with compounds 1- 8 as part of an ongoing 
collaboration. These samples were initially diluted in the 10 iL of DMSO and 1.tL 
removed. The sample was then dried under nitrogen for storage. The 1 tL was 
diluted in the required amount to methanol to reach a solution of 10 mM. The 
samples where then subsequently diluted in 10 mM ammonium acetate to the desired 
concentration for analysis. Samples in solution were discarded after use. 
Trifluroperazine was purchased from Sigma Aldrich UK, and dissolved in methanol 
to 1 mM. The sample was subsequently diluted in 10 mM ammonium acetate to 
reach the desired concentration for analysis. 
2.4 Protein preparation for analysis 
2.4.1 Protein quantification 
The concentration of protein in solution was calculated using the Bradford assay 
(123) using bovine serum albumin 0.1 mg/mL to 1 mg/mL as a calibration reference 
standard. Calmodulin was additionally quantified using Beer's law. Insufficient 
protein was available to calculate an extinction coefficient, therefore a value of 2906 
L mol' cm -1 at 280 nm was used (124). Extinction coefficients for CaM are reported 
to be —1500 L mor' cm -1 at 280 nm for plant derived CaM and other forms which 
only have one methionine, and -3000 L mol' cm -1 at 280 nm for CaM containing 
two methionines. UV absorbance was measured on a Eppendorf Biophotometer 




All chemicals, unless stated otherwise were obtained from Sigma Aldrich UK. 
Double distilled Ultrapure water from Millipore Milli-Q system. 
Ammonium acetate - Stock solution of 1 M ammonium acetate prepared from 
ammonium acetate (MWt 77.1 amu) in ultrapure water. Stock solution was adjusted 
to pH 6.8 by addition of ammonia solution and acetic acid as required. Stock 
solution was diluted to the desired concentration in ultrapure water. 
Calcium acetate - Stock solution of 1 M ammonium acetate prepared from calcium 
acetate monohydrate (MWt 176.2 amu) in ultrapure water and was diluted to the 
desired concentration in ultrapure water. 
Strontium acetate - Stock solution of 1 M ammonium acetate prepared from 
strontium acetate (MWt 205.7 amu) in ultrapure water and was diluted to the desired 
concentration in ultrapure water. 
Lead acetate - Stock solution of 1 M ammonium acetate prepared from lead acetate 
trihydrate (MWt 379.3 amu) in ultrapure water and was diluted to the desired 
concentration in ultrapure water. 
Magnesium acetate - Stock solution of 1 M ammonium acetate prepared from 
magneium acetate tetrahydrate (MWt 214.5 amu) in ultrapure water and was diluted 
to the desired concentration in ultrapure water. 
Cadium acetate - Stock solution of 1 M ammonium acetate prepared from cadnium 
acetate dehydrate (MWt 266.5 amu) in ultrapure water and was diluted to the desired 
concentration in ultrapure water. 
2.4.3 Removal of involatile salts 
Prior to analysis by mass spectrometry the protein was dialysed to remove the 
involatile salts. Due to the small volumes of protein being handled, 3000 MWCO, 
0.5 mL Slidealyser dialysis cartridges from Pierce (PerbioScience UK Ltd.) were 
used. 0.5 mL protein was dialysed at 4 °C against 5 L 10 mM ammonium acetate, 
pH 6.8 overnight unless stated otherwise. 
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2.4.4 Complex preparation 
Protein and ligand were mixed and left at room temperature for 20-30 minutes prior 
to analysis. Approximately 100 jiL sample was prepared for electrospray analysis, 
and 10 p1 for nanospray analysis. Sample and ligand concentration, unless 
otherwise stated was 20-50 .tM. 
2.4.5 Nanospray tip preparation 
For the experiments carried out on the Q-ToF gold coated glass capillary nanospray 
tips (Proxeon Biosystems, Denmark)were used. These were filled with '-10 tL of 
sample. The tip was then centrifuged briefly to spin out any air bubbles trapped in 
the tip. The tips were cut manually by snapping approx 1mm from the pulled end 
with a pair of tweezers. 
For the experiments on the 9.4 T FT-ICR, borosilicate glass capillaries were pulled 
using a model P87 micropipette puller (Sutter Instruments, USA) as described by 
Williams et al (125). 
2.5 Mass spectrometer settings 
2.5.1 Platform settings 
Platform II mass spectrometer (Micromass, UK) with electrospray interface and 
Masslynx versions 2.3 and 3.5. The instrument was calibrated weekly with horse 
heart myoglobin. 
2.5.1.1 Direct infusion 
Sample infused into the mass spectrometer by a syringe pump (Harvard Apparatus, 
USA) at 2 - 8 Ill,/mm. The probe capillary voltage was held at 3.5 kV and the 
sample cone at 50 V. The source was maintained at a temperature of 65 °C and the 
desolvation temperature 140 °C. The nebulising and desolvation nitrogen flow were 
maintained at 20 L/h and 350 L/h respectively. Data was collected in mca mode and 
an average of 10 scans was collected. 
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2.5.1.2 Flow injection analysis 
Sample introduced by autosampler loop injection into a continuous flow of solvent 
controlled by a Waters 2790 HPLC. The flow of ammonium acetate was maintained 
at 0.05 mL/min into which 10 tL of sample was injected. 
The probe capillary voltage was held at 3.5 kV and the sample cone at 50 V. The 
source was maintained at a temperature of 65 °C and the desolvation temperature 140 
°C. The nebulising and desolvation nitrogen flow were maintained at 20 L/h and 350 
L/h respectively. Data was collected in continuum mode and Openlynx software 
utilised to combine the scans at the maximum TIC intensity. 
2.5.2 Q-ToF settings 
Q-ToF I mass spectrometer (Micromass, UK) with Z spray source and controlled 
with Masslynx versions 3.5 and 4.0. The instrument was calibrated weekly in 
positive and negative ionisation modes with horse heart myoglobin. 
2.5.2.1 Electrospray 
Sample infused into the mass spectrometer by a syringe pump (Harvard Apparatus, 
USA) at 8 j.tL/min. The probe capillary voltage was held at 3.5 kV and the sample 
cone at 50 V. The source was maintained at a temperature of 65 °C and the 
desolvation temperature 140 °C. The nebulising and desolvation nitrogen flow were 
maintained at 20 LIh and 350 L/h respectively. Data was collected in continuum 
modes and between 1 and 10 minutes of data averaged to provide a spectrum. 
2.5.2.2 Nanospray 
Prior to application of voltage to the nanospray tip, approximately 5 psi of back 
pressure was applied to the tip to produce a small bead of liquid from the tip. 800 - 
1000 V was then applied to the nanospray tip to produce a steady spray. The counter 
electrode cone voltage was held at 50 V. The source was maintained at a 
temperature of 65 °C. Excessive kinetic energy was removed by colliding the ions 
with argon in the collision cell to a 10 psi and of which the acceleration voltage was 
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varied between 4 - 20 V. Data was collected in continuum modes and between 1 and 
10 minutes of data averaged to provide a spectrum. 
During collision induced dissociation the collision cell argon pressure was 
maintained at 10 psi unless otherwise stated and the acceleration voltage stepwise to 
45V. 
Negative ionisation conditions were the same as state above, but the opposite 
polarity. 
2.5.3 FT-ICR settings 
2.5.3.17 Tesla FT-ICR 
Bruker Daltonics 7 tesla FT-ICR with APEX II cart and analytica source. Solutions 
were infused at a rate of 1 pt/mm. The nebulising and drying nitrogen pressures 
were maintained at 50 and 30 psi respectively. The bias on the glass capillary was 
kept at -4500 V and a 100 °C drying gas was used to assist the desolvation process. 
Further desolvation was achieved by collisions of the ions with neutral buffer gas at 
the nozzle skimmer region using a -150 V capillary exit voltage. The pressure was 
maintained in the nozzle skimmer region to ----1 x 10 mbar by the use to a throttle 
valve on the rotary pump. Ions were accumulated in the hexapole for 1-2 seconds. 
All samples were collected using gated trapping, and excessive kinetic energy was 
removed by colliding the ions with argon pulsed into the cell to a pressure of -10 
mbar and the trapping voltage decreased to -0.5 V. Ions were detected using broad 
band data acquisition using an average of 50 scans containing wither 8 k or 1024 k 
data points. The original time domain free induction decay spectra were zero filled, 
guassian multiplied and fourier transformed. Data was acquired and processed using 
Xmass version 6.0.0 software (Bruker Baltronics, USA) 
2.5.3.2 9.4 Tesla FT-ICR 
BrukerDaltonics 9.4 tesla FT-ICR with APEX III cart and apollo source. Solutions 
were infused at a rate of 2 pL/min. The nebulising and drying nitrogen pressures 
were maintained at 40 and 40 psi respectively. The bias on the glass capillary was 
kept at --4500 V and a 100 °C drying gas was used to assist the desolvation process. 
Further desolvation was achieved by collisions of the ions with neutral buffer gas at 
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the nozzle skimmer region using a --100 V capillary exit voltage. Ions were 
accumulated in the hexapole for 1-2 seconds. All samples were collected using gated 
trapping, the trapping voltage decreased to —0.8 V prior to detection. Ions were 
detected using broad band data acquisition using an average of 50 scans containing 
wither 8 k or 1024 k data points. The original time domain free induction decay 
spectra were zero filled, guassian multiplied and fourier transformed. Data was 
acquired and processed using Xmass version 6.1.2 software (Bruker Baltronics, 
USA) 
2.6 Circular dichroism 
Measurements of the nNOS peptide were taken on a Jasco J-810 Cicular Dichrosim 
Spectrometer. Samples of the nNOS peptide were diluted to 100 [LM in the required 
solvent and analysed in a 0.5 mm cell. Spectra were acquired from 190 - 300 nm, at 
a scan rate of 5 run/min. 
2.7 Errors 
2.7.1 Mass errors 
The mass spectrometers were calibrated weekly with either horse heart myoglobin or 
sodium iodide/caesium iodide solution. The calibration however may drift over time, 
and the accuracy of mass on horse heart myoglobin (16951.5 Da.) over the week was 
calculated to be ±0.1% under optimal ionisation conditions (1:1 MeOH:H20 1% 
acetic acid). 
Under non denaturing conditions the accuracy of the mass spectrometers decrease 
and is estimated to be ±1%. 
2.7.2 Concentration errors 
Stock solutions of ammonium acetate and the divalent ion acetates were accurate to 
approximately ± 1%. 
Cyclophilin concentration was accurate to approximately ±2.5 jiM. 
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Calmodulin concentration however was less precise due to inability to calculate the 
concentration by the Bradford assay (section 2.4.1). Concentration calculated by use 
of the extinction coefficient and Beers law was accurate to approximately ±10 pM. 
Additional errors in concentration arose from the small volumes of sample handled. 
Routinely 1 p.L stock protein was diluted by 7 pL of 10 mM ammonium acetate. 
These small samples were manipulated by Gilson micropipettes which are at worst 
case (0.5 .tL from a 2 jtL pipette) have an error of ±5%. 
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3. Cyclophilin A non covalent complexes 
Cyclophilin A and its non covalent complexes were analysed by electrospray mass 
spectrometry. The aim was to: 
• Maintain the CypA:CsA complex into the gas phase and detect by MS 
• Investigate the conditions for optimal complex maintenance 
• Analyse a variety of CypA complexes 
• Develop a high throughput screen for a library of potential CypA ligands 
3.1 Proof of concept 
In order to establish the ability of the Micromass Platform II to retain and analyse 
non covalent complexes in the gas phase, the work of Ganem et al was repeated. 
The original work was carried out on the protein FK506 Binding Protein 12 (FKBP) 
and two ligands FK506 and Rapamycin (Ra) with a Kd of 0.4 nm and 0.2 nm 
respectively. As stated in section 1.3.1, this complex exhibits similar activity to 
CypA:CsA. 
3.1.1 FKBP - Retaining the folded protein 
FKBP was initially analysed at pH 7.7, close to physiological pH, figure 3.01A, 
under similar MS conditions used by Ganem et a! (56). The envelope of multiply 
charged ions ranges from z = 5+ to z = 8+. Addition of formic acid to 0.1% v/v to 
the sample lowers the pH, figure 3.0113, and a much broader range of multiply 
charged ions were generated from z = 6+ to z= 17+. 
This greater degree of charging indicates an unfolding of the protein. Acidic 
conditions would interrupt the intermolecular forces that help form the tertiary and 
secondary structure of the protein, allowing greater accessibility of charging to inner 
residues, resulting in higher charge states observed in the MS. 
Addition of ammonia solution to final concentration of 0.1% v/v, figure 3.01C, raises 
the pH of the sample and two distinct charge ion envelopes can be seen: one from the 
denatured protein and one from the folded protein. Not all proteins can refold in this 
way, once the intermolecular bonds determining the tertiary structure have been 
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destroyed. It is plausible that since FKBP has PPIase activity, this helps refold the 
protein. 
A 
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Figure 3.01 	Charged ion series of FKBP in a folded (A), unfolded (B) and 
partially refolded (C) conformation. 
3.1.2 FKBP:rapamycin complex 
The non covalent binding of Ra to FKBP is shown in Figure 3.02. The spectra of 
FKBP and FKBP:Ra in 1:1 ratio, clearly differ by a peak at 12734 Da. This is an 
increase in mass of rapamycin, 914 Da which corresponds well with the results 
presented by Ganem et al. 
The repeatability of the transfer of the complex from solution to gas phase was 
examined by analysing a sample of FKBP mixed with Ra in 1:1 ratio on five separate 
occasions on the Micromass Platform II mass spectrometer. The raw data was 
deconvoluted and the intensity of the free FKBP and the FKBP:Ra complex was 
recorded over 10 combined scans. The ratio of unbound to bound protein, shown in 
figure 3.03, stayed constant throughout the five repeats. 
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Figure 3.02 Deconvoluted spectra of FKBP and Rapamycin (A) and FKBP (B) 






Figure .j.U3 Kepeatability ot ratio of FKBP : FKBP:Ra 
3.2 Analysis of cyclophilin A by ES! MS 
The successful repeat of the Ganem experiment and the initial proof of a non 
covalent protein ligand complex surviving the desolvation of the mass spectrometer 
into the gas phase was encouraging and extended to another member of the 
immunophilin family, cyclophilin A. 
3.2.1 Mass of cyclophilin A 
Cyclophilin A was analysed from standard electrospray conditions to obtain a 
molecular weight for the protein. Two masses were obtained, the first at 17879 Da 
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which corresponds well with the mass calculated from the sequence (17881 Da). 
The second mass is 131 Da heavier at 18012 Da, which corresponds to an increase of 
methionine. Methionine is often used as a start codon in the transcription of the 
cyclophilin gene. 
3.2.2 Analysis of cyclophilin A under non denaturing conditions 
Cyclophilin was analysed from a solution which would retain the tertiary structure of 
the protein as described in section 1.2.2.2. Figure 3.04 shows that similar to the 
result obtained from analysis of FKBP, when electrosprayed from a solution buffered 
close to its physiological pH, the protein displays a reduced charged ion envelope, 
with charges from z= 7+ to z=9+. Whereas when the pH is lowered by addition of 
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Figure 3.04 Charged ion series of CypA in a folded (A), unfolded (B) and partially 
refolded (C) conformation. 
When analysed from non denaturing conditions (figure 3.04A), CypA maintains a 
compact charged ion series at high m/z indicating conservation of the tertiary 
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structure. However in comparison to optimal MS conditions shown in spectra B, the 
peaks are broad. This is due to adducts which often form at low charge states as 
described in section 1.1.4. Figure 3.04C shows the charged ion series obtained when 
the pH is raised after denaturing with acidic conditions. The spectra does not return 
to lower charge states and hence folded conformations. 
3.3 CypA and CsA 
3.3.1 Retaining the complex 
CypA and CsA were analysed in a 1:1 ratio from ammonium acetate, a non 
denaturing buffer. The spectra collected figure 3.05 clearly shows two separate 
charged ion series. Deconvolution of the spectra reveals that the 164 amino acid 
CypA and 165 amino acid CypA have both increased in mass by 1202 Da. This is 
the addition of CsA to CypA to form a complex. 
I 
Figure 3.05 25 iM CypA and 25 MM CsA in 10 mM ammonium acetate. Insert 
shows deconvoluted spectra 
Mi 
3.3.2 Specific association 
Only one ligand molecule was seen to bind to each protein molecule, which 
suggested that the binding is specific and not non specific aggregation caused by the 
desolvation process. This was further investigated by addition of methanol and 
formic acid to the sample. As can be seen from figure 3.06 when acid is added to the 
the binding of CsA to CypA is lost, and only the free protein is seen. Methanol and 
formic acid destroy the intermolecular bonding and the tertiary structure of CypA 
and hence the binding pocket is lost. 
A 25 tiM CpA 25 IJM CSA 
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Figure 3.06 A) CypA and CsA in 10 mM ammonium acetate. B) CypA and CsA 
in 10 mM ammonium acetate 5% v/v formic acid. Green circles, free 
CypA, Red squares CypACsA complex. 
Similar to the results shown for FKBP, not all the protein was in the bound 
conformation. The Kd between of CsA to CypA is quoted at 30nM (126), so at 20 
.tM in a 1:1 ratio at equilibrium exactly 50% of the protein should be complexed. 
Comparing intensities of CypA and CypA:CsA peaks, for instance at ±9 charge state 
in figure 3.05 indicates that more protein exists in the free form than in complexed 
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form. lonisation efficiencies of different molecules differ significantly in the mass 
spectrometer, however in the case of CypA and CypA:CsA the majority of the 
sample is the same and therefore the ionisation efficiency differences are assumed to 
be neglible. Therefore differences in intensities are probably due to partial 
dissociation of the complex during desolvation. 
The crystal structure of the CypA:CsA complex indicated a water molecule as one of 
the interactions involved in binding in the interface between the protein an ligand 
(83). However, the incorporation of water into the complex is not detected by the 
ESI method. 
3.4 Method optimisation 
Optimal conditions for retention of the cyclophilin cyclosporin complex were 
investigated on the Micromass Platform II single quadrupole instrument. Conditions 
were as stated in section 2.5.1, apart from the variable investigated. 
3.4.1 Solubility and solutions 
Various solvents were employed and assessed for their properties to dissolve the 
protein and ligands, and also for ability to retain the intermolecular bonding within 
the protein. The protein was easily dialysed from Hepes buffer into ammonium 
acetate buffer, with no precipitation problems. 
However cyclosporin was insoluble in anything apart from methanol and DMSO. 
Dilutions from the 4 mM methanol stock into 10mM ammonium acetate resulted in 
precipitation of the cyclosporin. 
Methanol can disrupt the intermolecular bonding in the protein, resulting in loss of 
the binding pocket, nevertheless, small amounts of methanol can be tolerated. 
Methanol has the added advantage of lowering the surface tension of the droplet 
aiding the formation of charged ions in the electrospray process. 
A compromise of 10% methanol in ammonium acetate was reached to ensure 
cyclosporin solubility 
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3.4.2 Cone voltage 
A 1:1 solution of cyclophilin:cyclosporin was infused into the mass spectrometer at 
increasing cone voltages to optimise the signal to noise ratio and maximise the 
amount of complex retained. The ratio of bound to unbound protein is tabulated in 
figure 3.07. 
Intensity  Ratio 
Cone 18011 Da 19215 Da Noise 18011 Da! 18011 Da 
voltage peak peak  19215 Da /noise 
30 57488 74564 14700 0.77 3.91 
40 84506 224160 10918 0.38 7.74 
50 173213 528073 10630 0.33 16.29 
60 319853 643298 12020 0.50 26.61 
70 447463 994688 25373 0.45 17.64 
80 710638 1497194 15554 0.47 45.69 
90 867193 1883475 17731 0.46 48.91 
100 980013 1978464 16414 0.50 59.71 
110 1499891 2034201 27294 0.74 54.95 
120 1701520 1902878 21832 0.89 77.94 
130 2504567 2565983 22248 0.98 112.57 
140 2157840 1249479 24157 1.73 89.33 
150 	1 3023534 	1 1306472 	1 19980 2.31 151.33 
Figure 3.07 Ratio of bound to unbound protein at different cone voltages 
The results indicate that a high cone voltage is desirable to obtain a high signal to 
noise ratio. The higher voltage accelerating the ions into more collisions and better 
desolvation of the ions is achieved. Conversely a low cone voltage is needed to 
preserve the protein ligand complex as high voltages and hence faster acceleration 
cause dissociation of the complex. Overall a compromise of 50 V was chosen to 
given the optimum signal to noise ratio whilst still preserving the complex. 
3.4.3 Capillary voltage 
At standard operating conditions the capillary voltage is 3.5 kV. It was possible that 
the preservation of the complex may be dependent on capillary voltage. High 
voltages may lead to fragmentation of the non-covalent complex. 
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Problems with protein production and purification resulted in insufficient cyclophilin 
available at the time the experiment was carried out on FKBP and rapamycin. It is 
probable that due to the similarity in properties of FKBP and CypA that effects on 
FKBP can be extrapolated to CypA 
The ratio of complexed to uncomplexed protein is tabulated in table 3. There is a 
slight trend towards lower capillary voltages. Further experiments revealed that 
capillary voltage has no effect on complexation. Other factors such as the age and 
storage of the protein and the inhibition time of the sample may be responsible for 
the variation in amount of complex. 




Figure 3.08 	Ratio of complexed protein at different capillary voltages. 
3.4.4 Concentration 
Further proof that the cyclophilin and cyclosporin are binding, and not just non-
specifically aggregating in solution was obtained by diluting the sample. Figure 18 
shows the m/z spectrum of cyclophilin and cyclosporin. The sample was analysed 
and then diluted in half, then reanalysed. This was repeated until the sample was too 
dilute to distinguish from the noise on the mass spectrometer. 
The charged ion series is shown in figure 3.09, comparison between similar charge 
states ie the Cyp + 9 peak at 2002 m/z and the CypCsA +9 peak at 2135 mlz is 
equivalent to comparison of deconvoluted data. Changing the concentration of the 
cyclophilin and cyclosporin solution does not have any effect on the ratio of free 
protein to complex. 
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Figure 3.10 CypA and CsA at increasing concentration of CsA 
Changing the ratio of concentration of cyclophilin to cyclosporin will affect the 
equilibrium of the species. and increase the amount of complex. Increasing the 
Cyclophilin A non covalent complexes 
amount of cyclosporin relative of that of cyclophilin, the amount of free cyclophilin 
decreases until at 5:1 cyclosporin:cyclophilin no free cyclophilin is detected by the 
mass spectrometer. The intensities of the peaks in figure 3.10 are tabulated in figure 
3.11. 
Ratio Cyp:CsA Intensity Cyp! Intensity CypCsA 
1:5 0 
1:2 0.65 
1: 	1 1.84 
Figure 3.11 	Change in complex intensity with changing cyclosporin concentration 
This indicates that the complex is strong enough to survive the electrospray process, 
and the free ligand and protein seen in lower ratio samples is due to free ligand and 
protein in equilibrium with the complex. When an excess of ligand is present and the 
equilibria is forced to the right towards full complexation of the protein, all the CypA 
present is complexed to CsA 
3.4.5 Resolution 
Improving resolution is a trade off with signal intensity. Spectra of CypA:CsA were 
collected at 12.5, 13.5, 14.5 and 15.5 values of resolution. The signal to noise ratio 
was calculated for each different resolution value. The results are tabulated below 
(table 5). 





Figure 3.12 	Signal to noise decrease with increasing resolution 
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Due to the age and also to varying storage conditions for CypA, the data suffered 
from formation of adducts which badly affected the signal to noise ratio. However 
an overall trend of greater signal to noise at lower resolution can be seen. The 
compromise of loss of mass accuracy when using lower resolution values on the 
quadrupole analyser in this case is not an issue, as the difference between the ligand 
and protein is of sufficient mass. Smaller ligands with less mass difference may 
require better resolving power, and may require analysis on a mass analyser with 
better mass accuracy and resolution. 
3.4.6 Inhibition time 
The optimum inhibition time of the protein and ligand prior to analysis was 
investigated. The binding of cyclosporin requires inversion of the cyclic peptide 
structure and orientation of the side chains. 
Intensity CypA:Intensity CypACsA 
Time (mm) 20 tM CypA 
20 jiM CsA 
20 jtM CypA 
20 jiM CsA 
I :5CypA:CsA 
5 187:100 74:100 51:100 
20 172:100 55:100 - 
40 142:100 73:100 - 
100 149:100 50:100 - 
180 188:100 63:100 - 
Figure 3.13 	Intensity taken from deconvoluted spectra of various ratios of 
CypA:CsA at different incubation times. 
The results in figure 3.13 suggest rapid complexation of cyclophilin and cyclosporin. 
In the 1:1 and 1:2 ratio solutions the maximum degree of inhibition normally seen at 
theses ratios is rapidly reached and the amount of complexed protein does not 
increase over time. In the 1:5 ratio solution, the inhibition process is still happening 
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at 5 minutes. This is possibly because a greater amount of protein is complexed at 
this ratio and time is needed to orientate the molecules. 
From these results, it was concluded to leave the protein and ligand in solution 
together for approximately 30 minutes before analysis to give sufficient time for the 
maximum inhibition to happen. 
3.4.7 Infusion rate 
The infusion rate of the sample into the electrospray needle, was investigated as it 
had it may be possible that higher infusion rates create larger droplets that do not 
desolvate properly and may be detrimental to complex preservation. It has been 
suggested that nanospray, which produces smaller droplets is beneficial to the 
retention of complexes through the desolvation process (16). 
In general the infusion rate had very little effect on the amount of inhibition seen. 
Lower flow rates caused poorer signal to noise ratio, due to less sample entering the 
instrument and it was therefore more difficult to distinguish the charged ion series 
and deconvolute the data. 
3.5 CypA:CsA on Q-ToF and FT-ICR 
The cyclophilin A used for these following experiments was overexpressed and 
purified using a His tag, and therefore the mass is greater than 18011 Da. Mass 
spectrometry of his-tagged cyclophilin A under optimal mass spectrometry 
conditions show the mass to be 20250 Da. 
3.5.1 Q-ToF 
The Micromass Q-T0F I is very similar in source design to the Micromass Platform, 
although the Q-T0F has a Z spray source unlike the Platform which has an on axis 
probe-orifice. Therefore it was predicted that much of the method for preserving 
complexes in the gas phase carried out on the Platform MS would be transferable to 
the Q-T0F. A sample of 1:1 CypA and CsA was analysed on the Q-T0F under 
electrospray and nanospray ionisation. 
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Figure 3.14 Charged ion series of CypA obtained via nanospray and electrospray 
The charged ions series obtained via electrospray of CypA on the Q-ToF was wider 
than it was on the Platform instrument. The main series was still centred on the z= 
+10 charge states, however there appeared to be a degree of unfolded protein, charge 
states +12 - +18. Various conditions were altered, including source voltages, 
temperatures, and vacuum pressures, however fully folded protein was not obtained. 
CypA analysed by nanospray conditions, provided an even higher degree of charges. 
Here the charged ion series was centred on z= +14, a much higher charge state than 
was ever observed on the Platform mass spectrometer. Varying charge states are not 
uncommon in nanospray, as discussed in section 1.1.3 and by De Pauw et a! (16). 
Charged ion series produced by nanospray can depend on the distance between the 
tip and the cone, and the diameter of the tip orifice. The larger the tip orifice the 
more fluctuation appears in the charge ion series. 
The higher charge states seen indicated a more open structure with a greater extent of 
solvent accessibility. This more open, partially unfolded structure may have lost 
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Cyclophilin A non covalent complexes 
Nevertheless, when 20 M CypA was analysed with 20j.tM CsA in 10 mM 
ammonium acetate pH 6.8 by nanospray, complex formation was seen in similar 
ratios as under ES! conditions on the Platform MS. 
Collisionally induced dissociation was performed on the CypA:CsA complex to 
probe the affinity between CypA and CsA. 10 psi of argon gas in the collision cell 
has very little effect on the spectra, reducing noise and adducts slightly, but not 
affecting the charge states or intensity of peaks. The voltage accelerating the ions 
into the cell was increased from 4 V to 40 V. Over this voltage the complex of 
CypA:CsA was reduced to free protein and ligand as displayed in figure 3. 
3.5.2 FT-ICR 
A sample of 33 iM CypA and 33 pM CsA was analysed on a Bruker 7 T FT-ICR 
with Analytica source in the Leary research group in University of California, 
Berkeley, CA. 
Figure 3.17 showed that complexes could be retained and analysed on an FT-ICR. 
Unlike the Platform and Q-T0F instruments, at a 1:1 ratio of protein to ligand, all of 
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Figure 3.17 Overlaid spectra of CypA in black and CypA:CsA complex in red 
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Figure 3.18 	Expansion of high resolution achieved on +9 charge state of 
CypACsA complex 
This work was repeated on the 9.4 T FT-ICR with Apollo source. Very poor ion 
transfer was achieved, and hence the signal obtained was very low intensity, even 
though many scans were accumulated. Due to poor signal intensity, low memory 
data sets (16k) were acquired to maximise the signal strength, and consequently no 
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Upon deconvolution, it was evident that the protein had degraded. This was 
probably due to the degradation of the His tag. Despite the degraded CypA, a sample 
of CypA and CsA was analysed on the 9.4 FT-ICR and a mass increase of 1202 Da 
was observed, indicating retention of the CypA:CsA complex. 
3.6 CypA and CsA derivatives 
Several synthetic analogues of cyclosporin A were screened against CypA. These 
analogues, detailed in figure 3.21 below, were supplied by Prof Manfred Mutter, 
University of Lausanne, Switzerland. 
MWt Chemical name 
Cyppep I (unil 014) 1372 EtPmp(Me)2 4-CsA 
Cyppep2 (uni1013) 1216 EtIle 4-CsA 
Cyppep3 (uni 1026) 1264 D-MeAla-EtPhe 4-CsA 
Cyppep4 (unil0l5) 1258 CsC(ljMeMc pro 2) 
Cyppep5 (unil025) 1216 D-MeAla 3 -EtVal4 -CsA 
Cyppep6 (uniIO04) 1202 EtVal 4 -CsA 
Cyppep7 (unil024) 1250 EtPhe4 -CsA 
Figure 3.21 	Point mutations made on CsA to make CsA analogues 
MeLeu 9—MeLeu 10---- MeVaI 11— MeBmt 1—Abu2 
Sar3 
D-Al a 	Ala , 	Me L e u -Val 	MeL e u 4 
Litrc 3.22 	3 letter amino acid code structure of CsA where amino acids involved 
in the hindin site arc h\\n in hold 
Stx (d1 the .5C\ en (:\ analeguc are Hcd n the ttuctuie 1 CsA shown in figure 
3.22. (nrep 4 is based on cvclosporin C (CsC). which differs from CsA by the 
( 	I,'ji]i 	 IHI 	iflTh',c 
presence of a threonine (Thr 2 ) residue replacing the amino butyric acid (Abu) in 
CsA. This was further functionalised to a pseudo-proline (127). 
3.6.1 CypA and cyclophilin peptide 1 
A 1:1 mixture of CypA and Cyppepl was analysed under complex retaining 
conditions by electrospray on the Micromass Platform II mass spectrometer (figure 
3.23). A mass increase of 1372 was observed, indicating the addition of one peptide 
to the protein. No signals were observed to indicate any addition of 2 or more 
peptides. This suggests that the binding is specific and potentially in the binding 
cleft of CypA. There is also a species with mass 77Da greater than the 
CypA:Cyppepl indicated by the peak at 19464 Da. This appeared to be the 
incorporation of ammonium acetate into the complex. 
Further studies involving decreasing the concentration of protein and ligand were 
carried out (figure 3.24). The ratio of CypA:Complex is unchanged throughout the 
serial dilutions and confirmed that the binding was likely to be specific and not non-
specific aggregation formed during the electrospray process. 
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Figure 3.24 	1:1 ratio of CypA and Cyppepi at different concentrations. green 
circles are free CypA and red squares are CypA:Cyppepl complex. 
The other synthetic peptides were also analysed by ESIMS to investigate their 
binding affinity for cyclophilin A as shown in figure 3.25 below. 








Figure 3.2 5, 	Table detailing the whether each peptide ftrms a complex with ('vpA 
All peptides apart from Cyppep 4 showed affinity for CypA. Cyppep 4 has major 
changes in the conformation at residues I and 2, which are within the binding 
domain of cvclosporin. Pseudo prolines are often used to studs- hioactive cis-prolvi 
( 	 I 	1 	.1 	diLl 	'I if1 
conformations (127) and the proline produces a structure significantly different from 
CsA, therefore it is unlikely that it will bind. 
The other peptides appeared to have similar or greater binding affinity than CsA, as 
their ratio of free protein:complex appeared to be smaller than with CsA. To probe 
the relative affinities, competitive binding studies were carried out. 
3.6.2 Competitive binding 
Competitive binding studies were carried out on 1: 1 1 ratios of CypA:CsA:Cyppep. 
In theory the ligand with the highest affinity should form a tighter complex, which 
the other ligand will be unable to perturb. 
Figure 3.26 shows the deconvoluted data six of the seven peptides verus cyclosporin 
A. Cyppep 6 could not be compared with CsA competitively as the molecular 
weights are the same. 
It appears that cyppep 1, 2 and 5 have the strongest affinity for CypA, as the amount 
of protein complexed to these peptides was about twice as much as that bound to 
CsA. Cyppep 2 and 5 both have molecular weights of 1216, only 14 heavier than 
CsA, which on a single quadrupole mass spectrometer is difficult to resolve on a total 
mass of —19000. Therefore it was difficult to determine the amounts of protein 
complexed to cyppep2 and cyppep 5, and that complexed to CsA. However the 
slight shoulder on the peaks indicated a ratio similar to cyppep 1. 
Cyppep I has a large modification which despite being remote from the binding 
region may increase affinity due to additional interaction between the long side chain 
and the CypA. Cyppep2 has relatively conservative modifications which do not alter 
the polarity or hydrophobicity of the side chain, therefore the reason for the increase 
in affinity is currently unknown. Cyppep S's main modification is the change in 
chirality to D-MeAla at position 4 which may be responsible for the affinity. 
Like cycpep 5, Cyppep 3 has changed chirality at position 3 however this showed 
similar affinity as CsA unlike cyppep5 which showed enhanced affinity. It is 
possible that enhancement in affinity that the change in chirality might gain is 
cancelled out by the reduction in affinity caused by the bulky phenylaline group 
\ hich has also been ifltrodUCcd at position 4. 
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Cyppep 7 figure 3.26 also has a bulky phenylalanine in position 4 and showed 
slightly lower affinity for CypA than CsA. 
Cyppep 4, as found previously had little or no affinity for CypA, and therefore the 
competitive binding study showed predominantly CypA:CsA complex. 
These small changes in structure of CsA appear to have an effect on the binding 
affinity for CypA, as predicted by Mutter and co-workers (128). ESI has here been 
shown to be an effective screen for determining increases and decreases in the 
affinity relative to a known ligand CsA. 
3.7 Synthetic mimics 
Nick Turner and co-workers at Edinburgh University have been designing and 
synthesising molecules which can inhibit cyclophilin A as potential drug candidates. 
Using LIDAEUS (129), a structure based docking system, dimedone (compound 1) 
was selected as having a structure which fits into the physiochemical nature and 
structure of the CypA binding site. Four of the molecules (compounds 2-5) based on 
dimedone were screened against CypA using electrospray mass spectrometry on the 
Micromass platform instrument. Initially 1:1 concentrations at 20iM of protein and 
ligand were used, however no binding was seen at these concentrations. The ratio of 
ligand was increased to 1mM, 50x that of the protein. 
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Figure 3.27 	Structures of potential CypA inhibitors, compounds 1-5, 
Figure 3.28 shows binding of compound 2 to cyclophilin, indicated by the peak at 
18388 Da. The deconvoluted data has poor signal to noise and there is a peak at 
18246 Da, 243 heavier than cyclophilin. This peak is of significant intensity, 
however is of unknown origin. It was possible that the peak was due to compound 2 
fragmenting at the ester bond and this fragment, of mass 234, was binding to 
cyclophilin. This was corroborated by the fact that compound 2 fragments to 231 
m/z and 234 m/z when analysed under normal electrospray conditions- data not 
shown. However this theory was later disproved during the screening of a library of 
similar compounds where a +234 peak was commonly seen (section 3.9). 
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Figure 3.28 Deconvoluted spectra of CypA and Comp2 
Compounds 3 and 4 did not show any inhibition of cyclophilin. This may be that the 
binding strength is weak and the complexes are not surviving the ionisation process. 
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Figure 3.29 	Deconvoluted spectra of CvpA and comp",' 
C\1ICi)t 	l]\C 
The complex of CypA:Comp5 can clearly be seen in figure 3.29 as a peak at 18387 
Da. Repeats of the experiment show apparent binding of two molecules of 
compound 5. In some cases, with the majority of the protein seen in the form of 
CypA:(comp5) 2 . (Figure 3.30) 
mass 
Figure 3.30 Deconvoluted spectra of CypA and comp 5 showing stoichiometry of 
I Cyp:2Comp5 
Further investigation revealed that the peak at 18785 Da. was actually a creation of 
the transformation program rather than a real peak. Compound 5 is prone to 
formation of multimers, as can be seen from figure 3.31 where it ionises as (M +H) +  
373 mlz, (2M + H) 745m/z, (3M+ I-I) 1117 m/z, (3M+ NH 3 ) 1134 m/z, (4M+ 
NH 3 ) 1506 m/z, (5M+ NH 3 ) 1879 m/z. These multirners of compound may be due 
to the high concentration of the ligand or may be related to the hydrophobicity of 
compound 5 in aqueous solution. 
Inclusion of the 1879 m/z peak in the area transformed eg from 1680 mlz —3500 m/z 
results in a spurious peak at 18785 Da. If the area transformed was reduced to just 
include the charged ion series eg from 1950 mlz - 3000m/z then the peak at 18785 
( \LHHhiIi .\ 	ci!cn I wpL\c 
disappears. The areas transformed are shown in figure 3.32 and their resulting 
transformations are shown in figure 3.32. 
comD5 
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Figure 3.30 Raw spectra indicting the formation of multimers of Comp5 
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Figure 3.31 	Raw spectra indicating the two different mass ranges deconvoluted for 
figure 3.32 
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Figure 3.33 	Deconvolution of the two different ranges indicates in figure 3.32 
Dilutions on the cyclophilin ligand solution were analysed to test if the amount of 
complexed protein changed. Figure 3.34 shows the concentrations of cyclophilin A 
and compound 5 and the amount of inhibition seen. 
Sample Conc. Cyclophilin iM Conc. Compound 4 iM protein/complex 
1 2 100 - 
2 5 250 3.43:1 
3 6 300 2.91:1 
4 10 500 2.73:1 
5 20 1000 3.30 : 
6 20 500 6.57:1 
7 20 200 9.18:1 
8 20 100 - 
9 20 20 - 
Figure 3.34 Amount of complex with changing concentration of compound 5 
L1uIw \ ni c'Icni 	IfliC\C 
The protein concentration of the sample I at 2 iM was so low that a very poor 
charged ion series was collected, which was barely distinguishable from the noise, 
and hence could not be transformed. Samples 8 and 9 did not show any inhibition of 
the protein. 
Overall, the results show that the ratio of protein to ligand has an effect on the 
amount of protein complexed. When the ratio of ligand to protein is 5:1, regardless 
of the concentration about 1/3 of the protein is complexed to ligand. However when 
the ratio of ligand to protein is decreased, in samples 6-9, the amount of complexed 
protein decreases as well, until no inhibition is seen. 
Other compounds 6-9 figure 335, synthesised by Gary Lindsay were screened 
against cyclophilin. 
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Figure 3.35 	Structures of potential FKBP inhibitors compounds 6 -8 
No increase in mass was observed at the predicted mass for the complex for the 
spectra of compounds 6-8 against CypA, and hence the compounds are thought to 
have little affinity for CypA. This is not surprising as the molecules were designed 
to have affinity for FKBP, nevertheless is a good control to show that non specific 
association is not occurring. 
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3.8 Towards high throughput Screening 
To screen many compounds affinity for Cyclophilin A by direct infusion was a very 
laborious process. The rate limiting steps were the manual filling of the syringe, and 
the cleaning of the syringe and transfer lines between samples to avoid sample 
contamination. Direct infusion of samples also requires continuous operator 
presence. On average, by an experienced operator, approximately 6 samples could 
be analysed per hour. 
Flow injection analysis (FIA) is a technique commonly used for automated mass 
spectrometry. It utilises a continuous flow of solvent into the mass spectrometer. 
Into this flow the sample is injected commonly via a rheodyne sample injection 
system. Samples can be injected manually or with an autosampler into the rheodyne. 
FIA was used to overcome many of the limitations of direct infusion analysis. An 
autosampler, reduced the operator assistane required, and the continuous flow flushes 
the system between samples, minimising sample carryover and contamination. 
A Waters 2790 Alliance HPLC was used to pump 0.2 mL/min of 10 mM ammonium 
acetate into the mass spectrometer. 	This instrument incorporates a built in 
autosampler. 50iL of sample was injected into the flow, through a UV detector set 
at 280 nm, and into the mass spectrometer. 
Initial results (figure 3.36) indicated that the protein was injecting, and passing 
through the system, as an increase in UV absorbance was seen. However, no 
corresponding increase in total ion count (TIC) was seen on the mass spectrometer. 
Combining mass spec scans 4-11 produced a charged ion series of the CypA:CsA 
(figure 3.37), but with very poor signal to noise intensity. The background noise 
appeared to originate from either water (H20 - 18 arnu) or ammonia (NH 4 - 18 
amu). 
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Figure 3.36 UV at 208 nm and Total ion count spectra of sample analysed by FIA 
/1 
Figure 3.37 Combined scans of TIC corresponding to the peak maximum in the 
Uv 
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Varying conditions were tried to improve the signal. Increasing the temperature to 
promote evaporation of residual solvent resulted in unfolding the protein and hence 
dissociating the complex. Reduction of the flowrate to 0.05 mL/min, and source 
temperature of 65 C provided the best compromise of preservation of complex and 
signal to noise intensity. As seen in figure 3.38 
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Figure 3.38 UV and TIC spectra of CypA and CsA under optimised FIA 
conditions 
A comparison of data collected by FIA and by direct infusion showed very similar 
results. 
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Figure 3.39 	Comparison of deconvoluted spectra collected through infusion and 
FIA methods 
Analysing the samples using FIA allows approximately 7 samples per hour to be 
analysed. Although this a great improvement on direct infusion, automation of the 
screen greatly increased the throughput of samples. This was due to the autosampler 
allowing samples to be analysed 24 hours a day, and therefore approximately 168 
samples over 24 hours. Direct infusion, due to operator fatigue could only plausibly 
analyse 40 samples over a 24 hours. 
Greater throughput can be achieved by increasing flowrate to 200 PL/min and the 
temperature to 100 C. This reduced the runtime to 3 minutes per sample, potentially 
doubling the number of samples run. However, this was at the expense of data 
quality, and although the complex was preserved and the data was interpretable using 
smoothing algorithms, the data is overall of poorer quality. 
3.9 Libra' work 
A library of potential synthetic ligands synthesised by the Turner research group was 
screened against CypA. The ligands were based on dimedone. The basic structure 
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Figure 3.40 	Structures of ligand library 
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The molecules were synthesised on combinatorial chemistry robots (130) and the 
yields and purity were lower than expected. Therefore prior to screening, each 
compound was analysed under ESIMS to ascertain a level of purity. This was a 
fairly crude method of assigning purity, and the compounds were banded into 4 
categories as shown in figure 3.41. 
Estimated purity 	 % of library 
75-100% 	 15.9 
50-74% 	 15.9 
25-49% 	 25.6 
0-24% 	 42.7 




Figure 3.42 Deconvoluted spectrum of CypA and compound in well El I 
The library was screened against CypA under conditions optimised on CsA. The 
ligand concentration was 50 times that of CypA, at 1mM to 20 tM. The purity of 
the ligand was assumed to be 100% when preparing the stock solution of ligand, and 
\ 	LJCfll 
therefore as the ligands were found insufficiently pure in the majority of cases the 
concentration of the ligand is in reality much less than 1mM. 
One compound of the 82 compounds screened showed possible binding. This was 
compound in well Eli of the plate, the structure and spectrum shown in figure 3.42. 
The deconvoluted spectrum shows a mass increase of 475, similar to the molecular 
weight of compound Eli, 477 Da. This indicates the binding of the molecule. The 
screening of the other compounds in the library occasionally showed peaks in this 
region, which did not correspond to the correct mass of that potential ligand, and 
hence couldn't be explained. This may be the case with this potential ligand and 
coincidentally the protein ligand complex peak and the unexplained peaks fall in the 
same place. Nevertheless the screen has picked the peak up and whether it is a false 
positive or true potential ligand can be clarified by further studies. 
The purity of this compound was over 75%, prior to analysis with cyclophilin. This 
library compound has a valine type group in position Y of the library template. The 
two synthetic ligands compounds I & 4, also have a valine type group in this 
position. The other 9 compounds in the library containing valine groups did not 
show any affinity for cyclophilin. When this was cross referenced against the % 
purity prior to screening however 4 of the compounds were in the 0-24% purity and 5 
in the 25-49 % purity brackets. This may have affected the results. 
The automated screening system developed has the potential to screen approximately 
170 samples in 24 hours. Other research groups have carried out similar work 
screening libraries of compounds for their affinity to a certain substrate (131-133) 
and libraries of 300 compounds and more have been analysed (133). Two separate 
approaches to screening of potential ligands by ESIMS have been achieved. 
Retention and detection of the entire complex by ESIMS (132, 133) or formation of 
the complex, followed by separation of the complex from the uncomplexed ligand, 
dissociation of the complex and analysis of the ligand by ESIMS (131, 134). The 
first method can be slow, unless many compounds are analysed competitively. This 
often required the resolving power of an FT-ICR MS to then determine which 
ligands have bound. The second method of screening has the advantage of not 
having to retain the complex into the gas phase, and using reverse phase 
I.; 
chromatography has enabled screening of >250,000 compounds per system per day 
(134). The second method could be utilised with Cylophilin A to increase 
throughput of the number of ligands screened. 
A recently developed automated nanoelectrospray system called the Nanomate (135) 
has all the advantages of conventional electrospray plus automated, high throughput 
analysis without carryover, and this has been utilised to investigate quantitative non 
covalent complexes (136). Low sample volume often requires nano electrospray but 
as discussed in section 1.1.3, this has problems with poor reproducibility of the 
relative shape of the tip and the capillary cone distance for each repeat analysis, 
however the nanomate overcomes these issues (136). 
3.10 Conclusions and future work 
Complexes of cyclophilin A and cyclosporin A were maintained and analysed by 
electrospray mass spectrometry. The cyclophilin A cyclosporin A complex was then 
used as a model complex to optimise the parameters best for maintaining an 
analysing complexes on a Micromass Platform II mass spectrometer. 
Several peptide analogues of cyclosporin A were analysed against cyclophilin A and 
some were shown to have a higher affinity for the protein than CsA. 
A library of potential of cyclophilin inhibitors based on the molecule dimedone were 
screened against cyclophilin A, one compound of which showed a degree of binding 
and was selected for further analysis. The development of this screen has sped up 
the search for lead compounds to inhibit cyclophilin A, however it could be further 
developed by utilising a nanomate injection system as discussed previously in section 
3 .9, or by separating the bound ligand from the unbound ligand and analysing the 
ligand only. 
The study of cyclophilin A and its complexes can be further probed by H/D 
exchange to probe the tertiary nature of the complex. Similar studies have been 
carried out on other proteins such as the protease inhibitor cystatin (137) and 
calmodulin (138). H/D exchange could also be used to probe the presence of the 
water molecules seen in the X-ray crystal structure. 
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4. Calmodulin non covalent complexes 
The successful maintenance and analysis of CypA:CsA complexes by electrospray 
mass spectrometry described in chapter 3 paved the way for the analysis of further 
biological complexes. Calmodulin (CaM), which is known to bind calcium and 
subsequently other peptides and proteins (111) as described in section 1.4.2 was 
chosen as an interesting system to study by electrospray mass spectrometry. CaM 
binding calcium ions and subsequently binding target proteins and peptides is a 
further challenge to retain into the gas phase. The aims were to: 
• Maintain CaM and Ca 2+  non-covalent complexes into the gas phase and 
detect by MS 
• Probe the structural changes of CaM upon binding Ca 2+  
• Use ESIMS to probe the biological activity of CaM to nNOS 
• Analyse the binding region between CaM and nNOS 
CaM complexes have previously been studied by ESIMS and some of these reports 
are repeated as a test system prior to analysis of a larger CaM complex. 
4.1 Mass spectrometry of Calmodulin 
Calmodulin is an acidic protein, therefore if all groups are charged it is likely to be 
best observed under negative ionisation conditions, however both negative and 
positive mass spectra have been published(47, 139, 140). 
Bovine calmodulin was analysed on the Q-T0F from a solution of 1:1 methanol 
water and the mass recorded as 16706 Da, which corresponds exactly with the mass 
calculated from the sequence of 16706 Da (82). It was found that calmodulin could 
be analysed by positive or negative ionisation. 
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4.1.1 Apo calmoduhn 
Apo calmodulin was obtained by complexing out the calcium ions using EGTA as 
described previously (section 2.2.1). All glassware and plastic ware was acid washed 
prior to coming into contact with the decalcified protein. 
Apo calmodulin was analysed from ammonium acetate made and contained in acid 
washed glassware. The decalcified sample was analysed under positive and negative 
ionisation conditions and the following spectra figure 4.1 and figure 4.2 obtained. 
Figure 4.01 	Positive ionisation nanospray spectra of Apo CaM from 10mM 
NH4OAc. 
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Figure 4.02 Negative ionisation nanospray spectra of Apo CaM from 10mM 
NH4 OAc 
Under negative ionisation conditions, the protein provided a more stable spray which 
produced a clear spectrum, with better signal to noise ratio, and less adducts than 
under positive ionisation conditions. The spectra established that apo calmodulin can 
be produced and with sufficient care, can be transferred to the gas phase without 
binding any calcium ions. The data collected from positive ionisation conditions is 
also interpretable; however the spectrum shows many sodium adducts which make 
peak assignment more difficult. Loo and co-workers (141) have similar problems 
with sodium ions binding to calmodulin under positive ionisation conditions. 
Apo calmodulin is probably more easily ionised under negative ionisation conditions 
due to the acidic nature of calmodulin. Overall there are 38 acidic amino acid side 
chains and only 15 basic side chains figure 1.21- introduction chapter, leaving the 
protein with an overall acidic nature in a pH 6.8 environment which will deprotonate 
well under negative electrospray conditions. 
4.1.2 Calmodulin and calcium 
Calmodulin has a high affinity for calcium as discussed in section 1.4.3 and will 
obtain calcium from the solution and surroundings in which it is stored unless 
specific efforts are made to keep the calmodulin calcium free. The sample of 
calmodulin received was analysed, in 10 mM ammonium acetate at pH 6.8. This 
sample was not treated to add or remove calcium ions prior to analysis. 
When ionised under positive ionisation conditions, an indication of a charged ion 
series was found, however the peaks are very broad and the signal to noise ratio very 
poor and hence no easily interpretable spectra were collected. The broadness of the 
peaks is possibly due to cations such as sodium bound to apo calmodulin under 
positive ionisation conditions as shown in section 4.1.1. Although sodium does not 
necessarily interfere with calcium binding, as they may not compete for the same 
site, the mixture of sodium and calcium peaks are unresolved by the mass 
spectrometer and hence make a broad peak which is difficult to interpret. The 
division of the intensity between so many peaks also decreases the signal to noise 
ratio. The source of the sodium is unknown, but sodium is ubiquitous, especially in 
glassware. 
Under negative ionisation conditions (figure 4.03) addition of calcium ions to 
calmodulin can be seen in the spectra as a broadening of the peak compared with 
figure 4.02. Magnifying a range of spectra (figure 4.04), the calcium ion addition 
can clearly be resolved. 
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Figure 4.03 	Negative ionisation nanospray of CaM. 
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Figure 4.04 	Magnification of 1000 - 1275 m/z region of figure 4.3 
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Using the deconvolution software supplied with Masslynx v 3.1, all charge states 
from the charged ion series were deconvoluted to give the spectra shown in figure 
4.05. Five peaks can be seen, starting at 16703 Da, (apo Calmodulin 16706 Da) and 
increasing by 37 or 38 mass units. These peaks correspond to the calmodulin 





Figure 4.05 	Deconvolution of negative nanospray spectra of CaM 
The algorithm that is used to deconvolute multiply charged ion series to the mass of 
the zero charge molecule assumes all charges to come from protons. Whilst this is 
true for the apo protein, for a metalloprotein some of the charge comes from the non 
zero oxidation state of the metal ion. 
In positive ionisation, the number of protons is hence overestimated and in negative 
ionisation underestimated and therefore in both cases the mass calculated by the 
deconvolution program is too low. An example of each is shown below, assuming 
that all the charges have come from the loss or gain of a proton. 
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Positive ionisation 
calculation 
(mlz * z)_(z *H) 
+10 charge state at 1686.8 m/z 
(1686.8 * 10)—(10 * 1) 
= 16.858 Da 
Negative ionisation 
calculation: 
(m/z * z) + (z * H) 
-10 charge state at 1684.8m/z 
(1684.8 * 10) + (10 * 1) 
= 16,858 Da 
However if +8 of the charges are attributed to 4 Ca 2+  in each case, then only 2 
protons need to be accounted for in positive ionisation, and an extra 8 protons are 
lost in negative ionisation. 
(1686.8 * 10)—(2 * 1) 
	 (1684.8* 10)+(18* I) 
= 16,866 Da 	 = 16,866 Da 
This mass calculated is called the apparent mass (142). 
As a result spectra shown in a deconvoluted format will have discrepancies in the 
masses and will only be labelled with the species that the peak corresponds to and 
not the mass. 
Closer inspection of the CaM charged ion series reveals that the number of bound 
ions changes with charge state. The Masslynx deconvolution programme was used 
to interpret the charged ion series in several regions as shown in figure 4.6. 
Deconvoluted spectra reveal that apo calmodulin generates higher charge states and 
that holo calrnodulin generates lower charge states. This is probably due to 
differences in the structure of calmodulin induced by the binding of calcium 
discussed previously. Apo calmodulin has a more open structure than calcium bound 
calmodulin and is therefore more solvent and charge accessible figure 1.22. The 
more conserved calcium bound calmodulin has less surface area accessible to solvent 
and charging and hence has a lower charge state ion series. The changes in the 
charge ion series that suggest a calcium induced change in structure add evidence to 
the calcium ions being specifically bound, and not non-specifically aggregating. 
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Figure 4.06 	Regions of m/z deconvoluted for figure 4.07 
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Figure 4.07 	Deconvolution of different charge states of CaM labelled with the 
number of calcium ions bound 
Predominantly the maximum number of calcium ions seen bound to calmodulin by 
electrospray is four, which suggests that the binding is specific to sites on the 
calmodulin, and is not merely non specific adductation of the metal ions to the 
protein. 
However on occasion a fifth calcium ion is observed bound to CaM. Experiments 
carried out with increased collision gas and voltage failed to remove the fifth calcium 
ion. This suggests that the ion is not merely an adduct, but has a degree of affinity 
for the calmodulin. The presence of auxiliary sites has been noted by several groups, 
and is discussed in more detail in chapter 5. 
4.1.3 Calmodulin on the FT-ICR MS 
FT-ICR mass spectrometry can provide unsurpassed resolution and accuracy as 
discussed in section 1.1.8. The analysis of CaM was attempted on the 9.4 T FT-ICR 
MS to provide unequivocal data on the binding of calcium and subsequently other 
metal ions. Calmodulin has previously been studied by FT4CR MS and shown to 
retain CaM:Ca complex, as well as apo CaM:ligand complexes and CaM:Ca:ligand 
complexes (55). 
Under normal mass spectrometry conditions of 1:1 methanol:water 1% acetic acid, a 
spectrum of calmodulin was obtained (figure 4.08). Deconvolution of this data, 
calibrated with ubiquitin, shows the CaM:2Ca 2 (figure 4.09) and additional sodium 
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Figure 4.09 	Spectra shown in figure 4.08, deconvoluted using Xmass software. 
The calmodulin sample was analysed out of water as a solvent, (figure 4. 10) and a 
smaller charge distribution, +8 - +12, was observed compared to under optimal MS 
conditions, +9 - +15. However the signal intensity was also significantly lower, and 
more spurious peaks were observed. Unexpectedly less calcium incorporation was 
also seen under these conditions, as a more conserved tertiary structure normally has 
more calcium ion inclusion. No additional calcium was added to the sample, the 
calcium coming from solvents and glassware. Therefore the differences in calcium 
addition here are perhaps due to differences in free available calcium in the two 
samples. 










!4C0 	 1.0D 	2000 	2200 	 n/z 
Figure 4.10 CaM in water analysed on 9.4T FT-ICR 
The calmodulin was analysed from 10 mM NH 4 0Ac to try and maintain the tertiary 
structure and calcium binding pockets, however despite trying various temperature, 
gas and voltage conditions on the FT-ICR no spectrum could be obtained. 
The calmodulin was analysed from 100 tM Ca(OAc) 2 to increase the calcium 
available, to try and form the CaM:4Ca 2 complex, however, again no spectrum 
could be obtained. 
Desolvation conditions in the Apollo source of the Bruker 9.4 Tesla FT-ICR are very 
different from those of the Micromass Platform, and Micromass Q-ToF. The 
vacuum in the FT-ICR is much lower, the source at approximately 1.3 * 10 mbar 
(gate valve open) and cell at 3.6 * 10 mbar, than in the Q-ToF which has higher 
source and analyser vacuums at 1.3 * 10.1 mbar and 1.8 * 10-7 mbar respectively, and 
overall a more gentle pressure gradient. As discussed by Robinson et a!, low 
vacuum pressure can have a detrimental effect on retaining large complexes in the 
gas phase (21). 
The FT-ICR also has less controlled heating and gas desolvation than the Q-ToF. 
The glass capillary in the FT-ICR is not directly heated, relying on heated 
desolvation gas which bathes the outside of the capillary. This gas is does not come 
into contact with the desolvating ions and therefore cannot aid desolvation. 
Insufficiently desolvated ions would produce a low ion count and hence 
unfavourable to detecting complexes by FT-ICR. 
4.1.4 Repeated Calmodulin complexes 
Calmodulin interacts with many proteins and enzymes as discussed in section 1.4.2. 
Some of these interactions have previously been studied by electrospray mass 
spectrometry (97, 143). In order to develop the technique of retaining protein metal 
non covalent interactions, and the suitability of the available instrumentation the 
following well known calmodulin systems were investigated. 
4.1.5 CaM with melittin 
The preservation of a gas phase complex of melittin (MWt 2844) and calmodulin 
(Mwt 16706) was first communicated by the research group of Michael Gross in 
1997 (47). They detected a 1:1 complex of CaM:Mel using electrospray ionisation 
and a prototype four sector tandem mass spectrometer. Both positive and negative 
ion modes were used. Calmodulin was detected with between one and seven calcium 
ions bound, however calmodulin that bound to melittin contained no less than 4 
calcium ions. 
Experiments were performed to repeat this work on the Micromass Q-ToF using 
nanospray ionisation. A sample of 1:1 CaM:Mel in calcium acetate was analysed 
under positive ionisation conditions and similar to Gross et cii, a complex was 
preserved figure 4.11. Calmodulin was ionised with 0-4 calcium ions bound (figure 
4.12) however the complex was only seen for CaM with 4 or more calcium ions 
bound, in agreement with the work of Gross. 
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Figure 4.12 	Deconvoluted spectrum of CaM and melittin 
A sample of CaM and melittin was analysed on the FT-ICR however no complex 
was observed. This may be due to the inability to retain the CaM:4Ca 2 complex in 
the FT-ICR source. 
4.1.6 Calmodulin complex with Trifluorperazine 
Holo calmodulin is also known to bind the drug trifluoroperazine (TFP) (90, 91). 
TFP is a potent antipsychotic phenothiazine-type drug, and TFP binding to and 
inactivation of calmodulin has been widely studied. The stoichiometry of TFP 
binding to calmodulin has been determined by several investigators (90) and reports 
range between two and seven drug molecules per CaM:4Ca 2 . 
A sample of calciated calmodulin was analysed on the Micromass Q-ToF, under both 
positive and negative conditions. No formation of complex between the protein and 
ligand was detected at ratios of up to 1:10 protein:ligand. It is not fully understood 
why the work of Cook eta/could not be repeated. Sufficient calcium was present to 
form the CaM:4Ca 2 , confirmed by the presence of a charged ion series 
corresponding to a mass of 16866 Da. The TFP was readily ionised, and gave a very 
intense signal in the mass spectra. It may be that this suppressed the ionisation of the 
protein and any complex that may have been formed, particularly at higher 
concentrations of TFP. 
4.2 Calmodulin and neuronal Nitric Oxide Synthase 
Calmodulin binds to nNOS. and has been shown to control NO synthesis by 
activating electron transfer through the enzyme (93). The protein cofactors are 
Heme (616 Da) and it binds one mole each of FAD (829 Da) and FMIN. (478 Da). It 
also requires tetrahydrobiopterin (BH4) which may stabilize the dimeric form of the 
enzyme (144. 145). nNOS can be inhibited by n-NOS-inhibiting protein (PIN) 
which may prevent the dimerization of the protein. The full amino acid sequence of 
nNOS predicts a molecular weight of 160970 Da. (145). 
4.2.1 Calmodulin with FMN domain of n Nitric Oxide Synthase by nESt 
A 28kDa fragment of nNOS containing the FMN and CaM binding domains 
(nNOS28) was prepared as described in section 2.4. The sample was analysed with 
calmodulin and calcium acetate under conditions optimised for retaining complexes 
in the gas phase. The sample was initially analysed by both positive and negative 
ionisation however maintaining a stable spray from the nanospray needle was 
difficult under both conditions. Positive ionisation overall yielded better data and 
typically 10 minutes of data was combined. 
The raw spectra shown in figure 4.13 as an insert, has poor signal to noise intensity, 
however, two charged ion series can be singled out from the background, the CaM 
(green circles), and nNOS28 which accounts for the majority of the other peaks. 
Further series are difficult to distinguish. The deconvolution of the raw spectra using 
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Figure 4.13 	MaxEnt deconvoluted spectrum of CaM (green circle), nNOS28 (open 
diamond). nNOS28:FMN (open triangle), CaM:4Ca:nNOS complex 
(red square) and CaM:4Ca:nNOS:FMN (red triangle). Insert A shows 
raw data 
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The deconvoluted spectra indicates the mass of the calmodulin (green circle) 
conformations at 16706— 16866 Da. The nNOS28 (open diamond) is seen at 28,210 
Da, and a smaller peak at 28,682 Da is the nNOS28 plus FMN (open triangle) its 
cofactor. The nNOS28 contains both the CaM and the FMN binding regions of 
nNOS. The signal at 45090 Da corresponds to the complex of CaM:4Ca 2 :nNOS28 
(red square). A peak is also seen for the nNOS28:FMN bound to CaM:4Ca 2 , where 
the ratio of CaM bound nNOS28:nNOS28FMN, 2.6:1 is similar to that obtained for 
the free nNOS28:nNOSFMN alone, 2.2:1 - the cofactor having no significant effect 
on the relative binding affinity. It is possible that all the nNOS is bound to the 
cofactor FMN and that some of the FMN is lost during the electrospray process, but 
nevertheless it does not appear critical to gas phase complex stability. 
Like the CaM:Mel complex analysed previously 4.1.5 the binding of CaM to 
nNOS28 is very specific. Expanding the region at 16700 Da figure 4.1313 shows that 
different conformations of CaM exist in equilibrium in the solution, CaM:0Ca 2 , 
CaM:2Ca2 and CaM:4Ca2 . The CaM:1Ca 2 and CaM:3Ca 2 seem to be depleted. 
Examining the CaM:nNOS28 complex, there are no peaks corresponding to the 
binding of anything apart from CaM:4Ca 2 and nNOS28. No other conformations 
+ i bind nNOS28. The depletion of the CaM:lCa 2+  and CaM:3Ca 2 s a phenomenon 
not seen in the repeated CaM complexes analysed by ESIMS. It has been previously 
been published that Ca binding to CaM is sequential and that 2Ca 2 bind to the C 
terminus with a higher affinity than the 2 to the N terminus(146). This depletion of 
these conformers in the mass spectra may be evidence of this. 
4.3 CaM complex with nNOS peptide 
Calmodulin potentially binds to a specific region of nitric oxide synthase predicted 
from its sequence to be residues 730 - 750 (145). Although not previously studied 
by mass spectrometry, the peptides of the CaM binding region of NOS have been 
synthesised and studied. Carafoli and co-workers (147) studied the interaction of 
CaM with a peptide of the binding region of nNOS, and other proteins' binding 
domains by fluorescence titration. The binding of calmodulin to the synthesised 
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binding region of eNOS studied by x-ray crystallography was published by Gertzoff 
et al(41). 
4.3.1 MS of CaM nNOS peptide complex 
The proposed CaM binding domain of nNOS was prepared as described in 
experimental section 2.3.2 and its ability to complex to calmodulin was analysed by 
electrospray mass spectrometry. Figure 4.14 below shows the spectra of CaM and 
nNOS pep under positive ionisation conditions. Spectra of the CaM nNOS pep 
complex can also be collected under negative conditions (figure 4.15). 
° free CaM o free nNOSpep D CaM:nNOSpep complex 
Figure 4.14 Positive ionisation spectrum of CaM and nNOS peptide. 
Like melittin, the nNOS peptide shows specific binding for the CaM:4Ca 2 
conformer. No binding is seen for any other conformer of CaM:xCa 2 . Similarly the 
binding of nNOS pep is preominant1y seen for the 4ower charge states, where the 
CaM:4Ca2  is the major coiformer. This is good evidence that the region of 
I 14 
Calmodulin non covalent complexes 
sequence predicted as the CaM binding domain, is in fact the correct domain and it 
has a high affinity and specificity for CaM:4Ca 2 . 
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Figure 4.15 Negative ionisation spectrum of CaM and nNOS 
The spectrum of the complex analysed under deprotonating conditions was similar to 
the positive spectrum, however the complex of CaM:4Ca:nNOS pep appears to be 
more abundant, and there was less free CaM in any conformation. No free peptide 
was seen; this is probably because the peptide is very basic and will not deprotonate 
well and therefore is not likely to be seen under negative conditions. 
4.3.2 CD of nNOS peptide 
Circular dichroism (CD) is a technique that allows the measurement of secondary 
structure in peptides and proteins. Structure is defined as helix, sheet or coil. 
The nNOS peptide was prepared for CD measurement and analysed under 
parameters described in section 2.6. The nNOS peptide was measured in ammonium 
acetate to confirm the structure in the buffer used for mass spectrometry 
measurements. The CD of nNOS peptide was also measured in methanol to mimic 
what the structure may be like in a hydrophobic environment, such as when the 
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calmodulin is wrapped around it. The spectra for nNOS peptide measured in 
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Figure 4.16 CD spectrum of nNOS pep in methanol and 10mM NH4OAc 
The spectra clearly shows that the peptide adopted different structures in the two 
different environments. When the peptide is free in solution (as seen from the 
ammonium acetate measurement) the structure is predominantly coil, with no 
increase at 200 rim to indicate helicity. However, when in a hydrophobic 
environment, similar to the environment when bound to CaM, and as mimicked by 
the methanol environment the structure was helical. 
This corresponds well with the x-ray crystallography data presented by Getzoff and 
co-workers (41) on the eNOS CaM binding domain. Strongly negative CaM is also 
known to bind to amphiphatic a helical peptides of smMLCK (101). The ability of 
the nNOS peptide to form a a helix, suggests it may form similar interactions to that 
seem by Getzoff and Linse. 
4.4 CID of Calmodulin complexes 
Collision induced dissociation (CID) was performed on the complexes of 
CaM:4Ca:nNOS pep under both positive and negative ionisation conditions. CID 
larel 
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was initially performed on the whole charged ion series to determine overall effect of 
dissociation, and the strength of the complex. CID was then carried out on single 
charge states to investigate the charge partitioning upon dissociation. 
4.4.1 Positive ionisation CID 
The complex of CaM and nNOS was analysed under positive ionisation conditions, 
and CID was performed on the whole charged ion series at a variety of acceleration 
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Figure 4.17 Positive ionisation CID spectra of CaM:4Ca:nNOSpep under 
increasing collision voltages. 
The data, although of poor intensity, shows the complex starting to dissociate at 
about 35 volts. The relative intensity of free protein to complex at 35 V was greater 
than at 20 V showing that some protein must be dissociated. There was also a 
corresponding increase in free peptide. 
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It was possible to isolate the z = +7 and z = +8, the two most abundance complex 
peaks by the quadrupole analyser prior to CID provided more information on the 
charge partitioning between the peptide and protein. 
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Figure 4.18 CID of isolated +8 charge state of CaM:4Ca:nNOSpep 
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Figure 4.19 CID of isolated +7 charge state of CaM:4Ca:nNOSpep 
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+8 complex 4 +6 CaM & +2 nNOSpep 
+8 complex - +5 CaM & +3 nNOSpep 
+7 complex -* +5 CaM & +2 nNOSpep 
+7 complex 4 +4 CaM & +3 nNOSpep 
The isolated +8 charge state of CaM:4Ca 2 :nNOS pep complex dissociated with the 
loss of +3 and +2 nNOS pep. Voltages of —40 V were required to produce a 
significant amount of dissociation of nNOS pep from the complex, higher injection 
energy than this resulted in complete loss of transmission of the complex or its 
dissociated constituents. A small amount of +9 free CaM:4Ca 2 is seen which may 
indicate an increase in protonation of the free protein. However it is more likely that 
the peak is a noise peak, as it can be seen in the background of the initial isolation of 
+8 and is artificially magnified by the loss in intensity of the +8 peak. 
The isolated +7 charge state of Ca:4Ca 2 :nNOS pep complex dissociated with the 
loss of predominantly +2 nNOS pep and at higher voltages +3 nNOS pep. Both the 
+8 and the +7 dissociation suggest that the +5 charge state of the protein was 
retained, however this was not seen in either spectra, which may be due to the fact 
that +5 CaM (3374.2 m/z) would appear in a region of the analyser where peak 
intensity is always poor. The +6 charge state would also be expected to be observed, 
as a dissociation product or +8 complex to +2 nNOS pep, however this was also not 
observed. It is possible that the charge stripping may have occurred, if the +8 charge 
state lost a proton to form the +7 charge state which then dissociated with the loss of 
the +2 peptide. 
4.4.2 Negative ionisation CID 
The complex of CaM and nNOS was analysed under positive ionisation conditions, 
and CID was performed on the whole charged ion series at a variety of acceleration 
voltages to assess the onset of dissociation. Under negative conditions it was hoped 
that the protein fragment would be seen, as it was very acidic and deprotonates 
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easily. It was not expected to detect the nNOSpep as it is very basic and unlikely to 
carry negative charge. 
Dissociation of the full charge series (figure 4.20) showed significant dissociation of 
the complex to protein at collision voltages of 40 V. The charge distribution for the 
complex (-9 to -12) is very similar to that of the protein (-9 to -11), which suggests 
that the dissociation under negative ionisation conditions may yield neutral peptide 
loss. Dissociation of isolated charge states was performed to probe the charge 
partitioning. 
:1011 
1001 	40V 	 r 







1001 	 by 
-14 	 2 1000 1200 	00 iROO 1800 2000 2200 2400 2800 	800 	
m 
Figure 4.20 Negative ionisation CID spectra of CaM:4Ca:nNOSpep at increasing 
collision voltages. 
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Figure 4.21 CID of isolated -8 charge state of CaM:4Ca:nNOSpep at increasing 
collision voltage 
Initial dissociations of the isolated -8 charge state of the complex appeared to show 
only loss of 1 negative charge from the complex. This is counterintuitive, as loss of 
a negative charge is effectively gain of a proton. The existence of -8 charge state for 
the complex in itself is slightly unusual, as the conditions were the same as for the 
full charge series CID. It is possible that the nanospray tip may have been causing an 
unusual charge effect (16) or that a contaminant was acting as a charge sponge or 
scavenger and reducing the charge on the complex. 
Repeat studies, resulted in full dissociation of the complex to free protein and nNOS 
peptide. 
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Figure 4.23 CID of isolated -9 charge state of CaM:4Ca:nNOSpep at 2 collision 
voltages 
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The dissociation of the isolated -9 charge state yielded -8 protein. A very small 
amount peak at 2408 mlz which due to the poor intensity was indistinguishable from 
either -8 complex (2410 mlz) or -7 protein (2407 mlz). This was repeated at higher 
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Figure 4.24 CID of isolated -10 charge state of CaM:4Ca:nNOSpep at two 
collision voltages 
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This appeared to confirm that the 2407 mlz peak was -7 protein. The fact that the 
protein in each case is carrying four Ca 2+  ions suggests that the complex ions 
observed with z = -9 and -10 actually possess -17 and -18 deprotonated residues, 
some of which may be present at the binding site. Compared to positive ionisation 
CID the complexes are more resistant to dissociation requiring a higher voltage to 
break the complex. This suggests a different structural form to the complex ion 
formed from positive ESI compared with negative ESI. The dissociation of the —10 
complex shows —9 and —8 protein, implying a corresponding peptide product with z 
= —1 or —2. The same occurs with dissociation of the —9 complex which dissociates 
to —8 and —7 protein, again suggesting loss of the peptide with a —1 and —2 charge. In 
both cases the protein retains all of its bound calcium ions, which is consistent with 
the findings of Derrick et al. (55) for low energy in source dissociation of the 
CaM:MLCK complex, although at higher collision energies they do observe break-
up of the CaM.4Ca 2 complex. 
As predicted no signals are seen corresponding to negatively charged nNOS peptide 
product ions as the peptide is very basic with only one acidic side chain, and it is 
difficult to observe as a deprotonated ion. The effective decrease in the charge state 
of the complex to form CaM products must be due to proton transfer from the nNOS 
peptide product, potentially forming a neutralised carboxylic group on CaM. For 
nNOS peptide this leaves an unobservable neutral species implying that binding at 
the CaM:nNOS interface is via at least one salt bridge interaction in the gas phase. 
This observation has been made by Getzoff et al (41) for the eNOS linker peptide, 
where strong interactions are present between the basic residues at the N terminus 
and several glutamic acid residues in CaM. In addition they describe a hydrophobic 
pocket created around methionine residues in CaM which is configured by specific 
residues in the (NOS) linker peptide binding loop. 
4.5 Conclusion 
The analysis of CaM and its complexes has shown that more information can be 
taken from mass spectrometry than simply molecular mass. Our use of CID and 
complementary techniques have interrogated this system allowing us to outline a 
number of important observations about the CaM:nNOS complex: 
Solution conditions alter the range of conformations available to the protein, analysis 
of the charge state distributions indicates that mass spectrometry can be employed to 
examine co-operative binding of metal ions at different sites within the protein. 
The specificity of the technique has been highlighted by the targeted binding of 
nNOS peptide to CaM4.Ca 2 . 
We have confirmed the proposed CaM binding site in nNOS peptide as residues 
Lys730 - Met750 via the specific binding of the synthesised nNOS peptide to 
CaM.4Ca2 . 
Collision induced dissociation yields charged products of both the protein and 
peptide which indicate that gas phase binding is partly mediated via electrostatic salt 
bridge interactions. 
This peptide is found to be helical in hydrophobic conditions such as those presented 
on CaM binding. 
The findings of Getzoff et al. (41) suggest that the CaM recognition sites within 
nNOS are similar to those in eNOS, due to the formation of an amphipatic helix with 
hydrophobic residues involved in CaM binding distributed along one side. The 
experimental work demonstrates that this peptide exhibits exclusive selectivity for 
the fully calcium loaded form of CaM which is the configured conformation required 
to accept the binding domain presented by nNOS. It appears likely that nNOS 
exhibits the classic 1-5-8-14 Ca 2+  dependent binding motif (139) where here I 
corresponds to residue 7 (Phe) in the nNOS peptide. 
Evidence from collision induced dissociation is that electrostatic salt bridge 
interactions are present at the binding site and are subsequently ruptured as the 
complex breaks up. This is proved by the charge reduction that occurs when the CaM 
product is detected as a negative ion which must correspond to proton transfer from 
nNOS peptide to the protein. Gas-phase complex binding will favour electrostatic 
above hydrophobic interactions, although the helical interior cavity of the complexed 
CaM (41, 143) suggests that here hydrophobic interactions must also play a part. 
Since it is apparent that the N terminal section of the nNOS peptide interacts with 
glutamic acid groups in the protein (41), we conclude that proton transfer is likely to 
( 	 c 
occur here, since this is likely to be not too deeply embedded in the hydrophobic 
helical cavity of the CaM protein. It is possible that the interactions involved in the 
complex obtained under positive ionisation conditions are somewhat different, there 
may be less deprotonated glutamic acid residues available for the electrostatic 
interactions, and hence charge is retained on basic residues on the peptide during 
dissociation 
4.6 Further work 
Future work could investigate the nNOS CaM complex by mutating out selective 
residues on the nNOS peptide or by taking the approach of Kondo el a! (148) and 
Gachhui et a! (149) who used mutated calmodulin chimeras to determine the effect 
of altering the complex interface on NOS activity. 
5. Calmodulin and divalent metal cations 
The successful maintenance and analysis of CaM complexes by electrospray 
ionisation mass spectrometry encouraged the examination of CaM with other 
divalent metal ions. ESIMS is particularly useful to analyse metal binding proteins 
as the mass of the metal ion and the isotope patterns can unequivocally identify 
which metal ions are binding, and ESIMS with sufficient resolution can even identify 
which oxidation state of the metal is interacting with the protein. 
The ionic environment inside a cell is very complex and various metals exist in a 
variety of concentrations and oxidation states. There is hence a need for metal 
binding sites to have a degree of selectivity. Many elements are present in biological 
systems. Eleven elements that make up 99.9% of the total number of atoms present 
in the human body of which 4, hydrogen, oxygen, carbon and nitrogen make up over 
99% (38). Competition between the metal ions for a protein binding site is an issue, 
particularly if a metal alien to the biological environment is present such as lead, 
mercury or cadmium. As discussed in section 1.4.5, the ability of heavy metals to 
displace or disrupt Ca 2 in CaM may be linked to their toxicity. 
The aims were: 
. Investigate the calcium ion binding of CaM 
• Analyse the binding of several alternative divalent cations and their ability to 
retain the tertiary structure 
As can be seen from the table figure 5. 1, along with the divalency, the cations chosen 
have at least one similar property to calcium which may explain their ability to 
displace calcium (150). The following parameters are some of those responsible for 
affinity between a binding loop and a metal ion: 
• The loop size which influences bond distance and bond strength to the 
encapsulated metal ion 
• The kind and number and positioning of donor groups in the loop 
• Hydrophobicity 
• Metal ion coordination geometry 
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Cation Coordination Ionic radii Hard or soft 
geometry (151) acid (152) 
(151)  
Ca' VI, VII, VIII, VII, 1.06 A hard acid 
MWt 38.1 XI, XII 
Mg 2+ IV, V, VI, VIII VI, 0.72 A hard acid 
MWt 22.3 VIII, 0.89A 
Sr'-- VI, VII, VIII, VII, 1.21 A hard acid 
MWt 85.6 IX, X, XII 
Cd24- IV, V, VI, VII, VII, 1.03 A soft acid 
MWt 110.4 XII 
Pb2 IV, VI, VII, VII, 1.23 A borderline acid 
MWt 205.2 VIII, IX. X, 
XI. XII  
Figure 5.01 	Table of properties of divalent anions analysed by ESIMS against 
CaM 
The ionic radii listed have been quoted from Shannon's 1976 paper (151). However 
different sources can quote slightly different radii. For example in Chao et al's paper 
on activation of calmodulin by metal cations, Ca  2 + ,  Mg2+  , Sr2-4- , Cd 2+ 2+ and Pb are 
quoted as 0.99 A, 0.65 A, 1.13 A, 0.97 A and 1.20 A respectively, however it does 
not mention what coordination geometry these radii are for (119). 
For this chapter the divalent charge of the metal will be omitted from the 
nomenclature when discussing the complexes for ease of simplicity. For instance 
2~ 	2± CaM:3Ca:lSr is actually CaM:3Ca :lSr 
5.1 Calmodulin and calcium 
5.1.1 Introduction 
As discussed in section 1.4 calcium binding properties of calmodulin have been 
widely studied and reported. It is known that calcium ions bind in a sequential 
manner (153) and that the binding affinity of the C domain is greater than for the N 
domain (114). Here the binding of calcium to calmodulin has been studied by mass 
spectrometry and the results compared to those already reported. 
5.1.2 Apo calmodulin and calcium 
Increasing amounts of calcium acetate were added to a solution of 25 tM 
calmodulin. The graph below (figure 5.02) plots the number of calcium ions 
complexed to calmodulin from the deconvoluted spectra, analysed by negative 
ionisation against total concentration of calcium added. 
In theory quantatively 4 times the concentration of calcium to calmodulin is needed 
to form CaM:4Ca. However from the graph below, it can be seen that the CaM:4Ca 
conformer is the dominant form by 10 iM, an order of magnitude less than was 
expected. It is possible that the concentration of calmodulin is effectively depleted in 
the ionisation process by adductation and therefore the spectra shown may not 
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Figure 5.03 	Deconvoluted spectra of different regions of the charged ion series 
Caimodulin and divalent metal cations 
A sample of 60 jiM calmodulin in ammonium acetate, to which no extra calcium was 
added, from the same nanospray tip was analysed under the same nanospray 
conditions in positive and negative ionisation. As shown in figure 5.03 it can be seen 
that different amounts of calcium appear to be incorporated under the different 
polarities. Charge states -7 to -9 in negative ionisation (5.03A) indicate the protein to 
be in the holo conformation, however if the full charge ionisation series is analysed, 
all five conformations exist. However the same sample analysed under positive 
ionisation conditions at +7 to +9 charge states (5.03C), the spectral distribution is 
distinctly different to the negative distribution, and the calmodulin is predominantly 
in the CaM:2Ca conformation. Analysis of the full charge ion series under positive 
ionisation conditions (5.03D) is similar to the negative (5.03B) in that all five 
conformations exist. However, the positive ionisation spectra show a higher degree 
of non specific metal adductation, particularly sodium, which is absent from the 
negative ionisation spectra (141). 
Other reasons the calmodulin seems to form holo calmodulin at less than 
stiochiometric concentrations of calcium, may be linked to an artificial strengthening 
of the calcium cation's affinity for the deprotonated calmodulin. When the protein is 
deprotonated there are many negatively charged residues, which may form an 
attraction with the positively charged calcium ion. However this would result in an 
increase in non specific association of cations, such as sodium, to the protein, and 
this is not seen. It is also possible that there are slight errors in the protein 
concentration as discussed in section 2.7. 
The co-operativity of binding between the EF hands as reported by Shepherd and 
Vogel (153) can be seen from the graph, figure 5.04 (an expansion of figure 5.02). 
The amounts of CaM:lCa and CaM:2Ca rise at the same concentration of calcium, 
indicating a degree of co-operation. As the first calcium ion binds and the second 
quickly follows. Similarly the formation of CaM:3Ca and CaM:4Ca are at the same 
concentration. It is not possible to tell which sites the first and second calcium are 
binding to, or if there is a propensity for a particular EF hand, or that the first and 
second calcium are binding to a separate domain than the third and forth calcium. 
However the concurrent formation of the CaM:lCa and CaM:2Ca before CaM:3Ca 
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and CaM:4Ca does strongly support the argument that calcium ions bind to 
calmodulin in a sequential manner and that calcium binding affinity is greater for one 
domain, reportedly the C domain (43, 141, 153). Further mass spectrometry 
analysis utilising mutations in the EF hand sequence to decrease the affinity for 
calcium could be used to probe the which EF hand and which domain the calcium 
has greatest affinity for. Gross et al (138), have pioneered a technique called Protein 
Ligand Interaction using Mass Spectrometry, Titration and HID Exchange 
(PLIMSTEX) to determine the binding constants of Ca to CaM. 
Figure 5.04 Expansion of the lower concentrations of figure 5.02 
The presence of a fifth calcium ion bound to a calmodulin homologue is noted by 
Murthy (140) at pH 7. In a tenfold excess of calcium, at pH's greater than 7, only 
CaM:4Ca is observed, and in acidic conditions less than 4 calcium ions are bound, 
until pH 2, where apo CaM is dominant. It is only at near neutral p1-I's utilising 
negative ionisation that a fifth calcium ion is reported. This correlates well with our 
data obtained at pH 6.8. However, a fifth calcium ion is also reported by Loo and 
co-workers (141) as non specific binding when calcium ion concentration was 1000 
fold greater than CaM concentration. The concentrations of free Ca 2+  here are far 
less than the 1000 fold excess stated by Loo and co-workers, and the fifth calcium 
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ion is unlikely to be entirely non specific as it does not dissociate using CID. It is 
possible that although calcium ions prefer binding into an EF hand, there may exist 
additional auxiliary sites outside this motif. When competition binding studies are 
carried out between calcium and magnesium, as discussed later in section 5.2, up to 7 
calcium ions are observed interacting with calmodulin. 
Evidence of up to 6 auxiliary cations bound to CaM have been reported by several 
groups (114, 116, 120) by a variety of methods including fluorescence (120), flow 
microcalorimetry (116), equilibrium gel filtration (116) and mass spectrometry (114), 
up to 10 cation sites are reported on caimodulin. The four capital Ca 2+  sites are the 
EF hands and binding therein causes the major structural changes. 
Calas and co-workers (114) suggest that the discrepancy in auxiliary sites between 
their results and that reported by Loo and co-workers, may be related to differences 
in ionisation, and the use of negative mode and deprotonation of the sample. They 
propose that the protein tertiary structure can be modified by protonation and 
deprotonation and this can influence the non covalent binding of the ligand. It 
follows that the auxiliary sites are unable to bind Ca 2+  at basic pH. 
In this case the calmodulin is analysed at near neutral pH, and close to physiological 
conditions, and therefore optimal conditions if the auxiliary sites are of physiological 
importance. 
Nevertheless, the allosteric effect of metal binding sites on Calmodulin is widely 
reported. Mills and Johnson (120) report that several metal ions are capable of 
binding to sites which are distinct from the calcium binding sites and produce an 
active conformer of calmodulin which exhibit enhanced affinity for felodipine. 
Some of the metals investigated, La 3+'  Tb3 , Pb2 , Sm3 , Sr2 , Hg2 , Cd2 , Zn2 , and 
Mn2 can compete with calcium binding sites and some can alter calmodulin's 
structure beyond the effect of calcium alone. It has also been reported that 
calmodulin may be a mediator of some of the toxic effects of these metals in heavy 
metal toxicity (119). 
5.1.3 Calmodulin and calcium conclusions 
Mass spectrometry has shown CaM to have four specific calcium ion binding sites. 
It also provides supporting eveidence of auxiliary sites as reported by Milos et al. 
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(116). Investigations into the concentration of calcium required to bind to CaM has 
suggested that the binding of calcium ions 1 and 2 and that of 3 and 4 is cooperative. 
It also suggests that the two lobes have different affinities for calcium binding. 
5.2 Calmodulin and magnesium 
Magnesium is situated above calcium in group II of the periodic table and shares 
many of its properties. It is therefore an obvious competitor for calcium binding 
sites, particularly as it is abundant in the body. Calcium dependant regulation in the 
cell is achieved by a transient increase in cytosolic Ca 2+  concentration from less than 
0.1 iM to 1-10 jiM, in a background of Mg 2+  concentration of 0.5-20 mM. This 
suggests that the EF hands must have a degree of selectivity for calcium above 
affinity alone. 
5.2.1 Apo calmodulin and magnesium 
Calcium ions were removed from the calmodulin using EGTA as described 
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Figure 5.06 Deconvoluted spectra of apo CaM (A) and apo CaM to which 
increasing concentrations of Mg(OAc) 2 had been added (B,C) 
Magnesium appears to bind to apo calmodulin, however unlike calcium this doesn't 
result in a major change in charge distribution to '--8, which would indicate a more 
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compact structure. Magnesium's affinity for CaM appears to be less than that of 
calcium, as at 250 jiM of metal acetate, less magnesium is bound (figure 5.06C) than 
calcium which is in the holo form by 100 jiM (figure 5.02). Increasing the 
concentration of magnesium acetate to 500 jiM increases the amount of magnesium 
ions bound, however there is no propensity for 4 metal ions (figure 5.07). Overall 
this infers that calmodulin has a lower affinity for magnesium than calcium and also 
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Plotting the change in number of magnesium ions bound against magnesium acetate 
concentration (figure 5.08) shows there are no allosteric trends in magnesium ion 
binding unlike with calcium (figure 5.02). 
To test whether the magnesium ions were merely adducting to the calmodulin during 
the electrospray process, the collision voltage and gas pressure in the collision cell 
were increased. Due to poor ion intensity and transmission, only voltages up to 35 V 
were applied, however this was insufficient to remove the magnesium, suggesting an 
affinity between the calmodulin and the magnesium beyond non specific adductation. 
A further probe of whether magnesium caused the same structural change as calcium, 
and the exposure of the central helical binding site, was the addition of the nNOS 
peptide to the CaM:Mg complex. No complex of CaM:Mg:nNOS peptide was seen, 
however a small amount of CaM:4Ca:nNOS peptide was observed. The sample of 
nNOS peptide was not treated with EGTA to remove metal ions; therefore some free 
Ca 2+  may be present that bound to the CaM which formed a complex with the nNOS 
peptide. 
5.2.2 Calmodulin, calcium and magnesium 
To probe the competition between calcium and magnesium for the metal ion binding 
sites on CaM, magnesium was added to calmodulin which had not been treated with 
EGTA to remove the calcium ions. 
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Figure 5.10 Deconvoluted spectra of CaM with which Ca(OAc) 2 has been added 
(A) and then increasing amounts of Mg(OAc) 2 (B,C) 
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The raw spectra show slight changes in distribution. Spectrum B shows a decrease in 
lower charge states, however this may be due to the nanospray tip as described in 
section 1.1.3. The deconvoluted spectra show addition of Mg 2+  to CaM:4Ca, 
however no displacement of Ca 2 is seen, suggesting that calcium has a significantly 
higher affinity for the EF hands than magnesium. Interpretation of the deconvoluted 
spectra is ambiguous due to the resolution limitations of the Q-ToF mass 
spectrometer. CaM:4Ca:2Mg has a similar mass to CaM:5Ca, and are unresolvable 
on the Q-ToF as can be seen in figure 5.10 C. 
Increased collision pressure from 10 to 15 psi, and voltage from 20 to 50 volts does 
not displace the added magnesium ions indicating they have a strong affinity to the 
CaM, perhaps in the auxiliary sites. 
5.2.3 Calmodulin calcium magnesium and nNOS peptide 
To investigate whether the binding of magnesium to the auxiliary sites on CaM, a 
sample of CaM, Ca(OAc)2, Mg(OAc) 2 and nNOSpep was analysed. This 
heterogeneous mixture proved difficult to ionise, however the best spectra obtained 
are shown in figure 5.11. Increasing the concentration of Mg(OAc)2 to maximse the 
amount of Mg 2+ binding to CaM, suppressed the ionisation of the protein and its 
complexes. 
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Figure 5.11 Raw spectra of CaM + Ca(OAc) 2 + Mg(OAc) 2 (A) to which nNOSpep 
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Figure 5.12 Deconvoluted spectra of CaM + Ca(OAc)2 + Mg(OAc) 2 (A) to which 
nNOSpep is added (B) 
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The deconvoluted spectrum indicates a mass increase to 19200 Da for both 4Ca and 
4CaMg corresponding to that of nNOSpep. This suggests that Mg 2+  does not affect 
CaM:4Ca's ability to form complexes, but since it is only seen in addition to 4Ca 2 
again it can be concluded that Mg 2 binds in auxiliary sites. 
5.2.4 Magnesium conclusions 
Magnesium ions are shown to have a lower affinity for CaM than calcium as 
evidenced by the requirement for higher concentrations of metal acetate to form 
CaM:xMg than CaM:xCa. Addition of magnesium ions to apo CaM failed to show a 
change in charge distribution indicative of a change in structural conformation and 
shows no tendency to form a CaM:4Mg conformation over other CaM:xMg 
conformations. 
Vainiotalo and co-workers reported similar results, stating no preference for 1:4 
stoichiometry of CaM:Mg (55). Analysis carried out in the same study, reported that 
the addition of Mg to CaM:Ca:peptide showed a decease in intensity of 
CaM:Ca:peptide and increases in intensity of CaM:Mg. It was extrapolated that 
Mg 2+ displaced Ca 2+  if present in excess, but was unable to maintain the CaM:4Ca 
conformation, this is similar to results obtained here as shown by the lower signal 
intensity in figure 5.1 lB. 
Magnesium ions are reported to decrease the affinity of calcium for CaM (43, 117, 
154). There is no indication of this occurrence in the ESIMS data collected, the 
sample of CaM with Mg and Ca figure 5.09C, very similar to CaM Ca figure 5.09A 
and shows no apparent loss of affinity of Ca. 
The Mg 2+  ion is up to 30% smaller than Ca 2+ and this may indicate why it is unable 
to bind in a similar fashion to calcium ions. Chao and co-workers report that several 
cations with significantly smaller radii, such as Be 2+'  Mg2 , Ni2 , CO2 , and Zn2 do 
not promote a structural change similar to Ca 2 (119). 
Magnesium has reputedly a higher affinity for the N terminus domain, unlike 
calcium which has a preferential affinity for the C domain (117). There is little way 
of showing which site is bound first via basic mass spectrometry, however 
PLIMSTEX and other H/D exchange techniques, along with point mutations in the 
CaM sequence could reveal the succession of Ca 2+  binding. 
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No structure of Mg - CaM is available, however, the NMR data suggests that a 
coordination similar to that revealed in the EF hand of Mg - Calbindin D9K, where 
the binding of magnesium, which adopts 6 coordination, is achieved in the EF hand 
in a way similar to that of 7 coordinating calcium. The Mg 2+  is coordinated by the 
same ligands as Ca2 , apart from one interaction, between the Ca 2 and a glutamic 
acid which is replaced by a water molecule with Mg 2 (117). The bidentate Ca 2+  
ligation by the side chain carboxylate oxygens of this glutamic acid have been found 
to be crucial for Ca 2+  induced structural rearrangement (155-157). 
5.3 Calmodulin and strontium 
Like magnesium and calcium, strontium is also a member of group II of the periodic 
table and therefore shares similar properties as described in section 5. However, 
unlike magnesium and calcium, strontium is not biologically essential in mammals 
but does exist as a trace metal in the human body (158). Toxic symptoms due to 
overdosing of strontium have not been reported in humans; nevertheless intravenous 
administration of high doses of strontium induces hypocalcaemia - deficiency of 
calcium in the blood - due to increased excretion of Ca. It is possible strontium is 
acting similarly to calcium in the body and this is the cause of its mild toxic effects. 
5.3.1 Apo calmodulin and strontium 
Strontium was added to calmodulin from which calcium had been chelated out. 
Increasing concentrations of Sr(OAc) 2 were added to 25 p.M CaM, and analysed by 
nanospray on the Q-T0F. The spectra (figure 5.13) show addition of Sr2 ions to the 
calmodulin. There is no shift in the charged ion series to lower charge states 
indicating a contraction in the tertiary structure of the protein, similar to that seen 
with calcium ions. However, deconvolution of the data, figure 5.13C, shows that the 
CaM has affinity for up to four strontium ions at a concentration of 250 p.M 
Sr(OAc)2. This suggests that the Sr 2+  ions may be binding into the EF hands. 
Increasing the concentration of available Sr 2+  still further to 500 p.M Sr(OAc) 2 , 
promotes further binding of Sr 2+  to CaM (figure 5.15), and there is a propensity for 
the CaM:4Sr conformation, similar to that of CaM:4Ca. 
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Formation of the CaM:4Sr takes place at a higher concentration of Sr(OAc) 2 , 
approximately 250 [iM, than the CaM:4Ca (which is formed with Ca(OAc) 2 at 
approximately 50 .iM). This suggests that CaM has at least a five fold lower affinity 
2+ 	2+ for Sr than Ca 
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Figure 5.14 Deconvoluted spectra of apo CaM (A) and apo CaM to which 
different concentrations of Sr(OAc)2 had been added (B,C) 
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Figure 5.15 -11 charge state of 25 jiM CaM and 500 jiM Sr(OAc)2 indicating the 
number of strontium ions bound 
The graph in figure 5.16 shows the relative intensity of each complex with increasing 
concentration of strontium. The graph indicates that there may be cooperativity in 
the binding of the first and second strontium and the third and forth strontium, 
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of the first and second metal ion follow a similar trend, showing a similar degree of 
binding at 100 p.M Sr, both reaching maximum binding at 200p.M before deceasing 
in intensity, as the CaM:3Sr, and CaM:4Sr conformations start to form and dominate. 
The cooperativity between the third and fourth strontium binding is not as defined as 
strontium one and two, however still follows a degree of similarity. The fifth 
strontium binding is similar to that seen with calcium binding; although this complex 
forms at much higher concentrations than for calcium. 
Overall the strontium binding graph is comparable with the calcium binding graph, 
indicating that the strontium may be binding in a similar fashion to calcium in the EF 
hands. 
strontium acetate conc (pM) 
• 0 S 
1 Sr 
25r 
V 3 S 
4 S 
5 S 
Figure 5.16 Graph of increasing concentration of Sr(OAc) 2 vs conformations of 
CaM :xSr 
5.3.2 Calmodulin, calcium and strontium 
Strontium was added to a sample of calmodulin from which the calcium had not been 
previously removed. As the strontium acetate concentration was increased relative to 
the CaM concentration the number of strontium ions bound to the calmodulin 
Calmodulin and divalent metal cations 
increased as can be seen from the figure 5.17 below. The amount of calcium in the 
sample is unknown as it was not quantifiably added here. 
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Figure 5.17 CaM (A) to which increasing amounts of Sr(OAc)2 has been added 
(B,C,D) 
Increasing concentration of strontium does not have a marked effect on the overall 
charge distribution, suggesting no major changes in tertiary structure. Closer 
inspection of each charge state shows the incorporation of strontium increases at 
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Figure 5.18 	Deconvoluted spectra of CaM (A) to which increasing concentrations 
of Sr(OAc) 2 has been added (B,C,D) 
When all charge states are deconvoluted to give the mass of the complex a trend 
appears. The strontium appears to bind into any vacant EF hands to form a 
calmodulin complex with a total of 4 metal ions bound. At high concentrations of 
strontium it appears that strontium may even displace calcium from the EF hand. 
This is indicated by the appearance of CaM:4Sr at a concentration of 200 [LM 
Sr(OAc) 2 . There is still apo CaM present, which suggests that the CaM 4Sr is not 
complexing to the apo form, but rather forming by displacing calcium. Calmodulin 
in greater concentrations of Sr(OAc) 2 were analysed, but as with magnesium the 
signal was suppressed, and no interpretable data was obtained. 
To simplify whether the strontium was displacing the calcium from the EF hands 
known amounts of strontium and calcium were added to calmodulin. Figure 5.19A 
below, shows the spectra of holo calmodulin, formed by the addition of 25 1.tM CaM 
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and 50j.iM Ca(OAc)2, and figures 5.1913 and C show the addition of 50 jtM and 
1 00M amounts of Sr(OAc)2 respectively to this sample. 
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Figure 5.19 Raw spectra of holo CaM (A) to which increasing amounts of 
Sr(OAc)2 has been added 
The data clearly shows holo calmodulin, and a fifth calcium bound. Addition of 
strontium acetate shows the formation of a new conformer, equivalent to 
CaM:3Ca:lSr. This complex may have formed via CaM:3Ca, or by CaM:4Ca with 
the displacement of a calcium. It is more likely to be by the latter, as CaM:3Ca still 
exists in the spectrum. Further addition of strontium acetate, to 100 jiM, produces 
greater amounts of calmodulin calcium strontium complexes. The biggest complex 
at this concentration appears to be CaM:4Ca:2Sr, although the mass is a little low. 
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Figure 5.20 Deconvoluted spectra of holo CaM (A) to which increasing 
concentrations of Sr(OAc)2 has been added (B,C) 
This is a total of 6 metals bound and therefore auxiliary metal ion binding sites must 
be being utilised. From the full charged ion series (figure 5.19) Strontium ion 
binding appears to be greater at low charge states, higher m/z. This may indicate that 
the strontium is non-specifically binding as adductation is greater at lower charge 
states, for instance Na adductation. CID was performed to probe the strength of the 
CaM:4Ca: I Sr association. A degree of dissociation of the strontium ion from the 
CaM:4Ca complex was seen at 45 collision volts. 
5.3.3 Calmodulin, calcium, strontium and nNOS peptide 
The nNOS peptide was added to a sample of protein which has been exposed to 
calcium and strontium. 
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Figure 5.21 Raw spectra of CaM + Ca(OAc) 2 + Sr(OAc)2 (A) to which nNOSpep 
is added (B) 
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Figure 5.22 Deconvoluted spectra of CaM + Ca(OAc) 2 + Sr(OAc)2 (A) to which 
nNOSpep is added (B) 
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The binding of the peptide to the protein indicated that the tertiary structure of the 
calmodulin is retained and hence the hydrophobic linker between the N and C 
terminus domains is accessible. Although prior to binding the peptide yielded a wide 
charged ion series and many CaM:Ca:Sr complexes, this changes to a much 
narrower, less charged distribution with predominantly CaM:4Ca:nNOSpep and 
CaM:3Ca:lSr:nNOSpep complexes. This reduction in the charged ion series and 
decrease in number of CaM complexes may be due to a change in equilibrium of the 
available calcium. The nNOS peptide is synthetically made and has not been 
purified to remove any ubiquitous calcium. 
Nevertheless, one of the peptide complexes is CaM:3Ca:lSr, which indicated that the 
strontium has displaced the calcium from an EF hand and that this form of CaM will 
maintain the tertiary structure of the calmodulin. 
5.3.4 Strontium conclusion 
From the data collected it appears that strontium will bind to the EF hands in a 
similar fashion to calcium. It however appears to have a lower affinity than calcium 
and it does not appear to displace calcium unless present in a much greater excess. 
The properties of Sr2 are very similar to Ca 2+.  Unlike Mg2 , Sr 2+  has a VII 
2+ coordination geometry, and although slightly larger than Ca , this appears to enable 
strontium ions to mimic aspects of calcium binding to CaM although with a lower 
affinity. 
Strontium does not appear to have a strong affinity for auxiliary metal ion binding 
sites remote from the EF hands, although some auxiliary site binding is seen at high 
concentrations of strontium. This correlates well with the results of Milos et al (114, 
116) who state that calcium and strontium would bind selectively to the principle 
sites; other metals such as zinc, manganese, copper and mercury would bind 
specifically to the auxiliary sites and a third class including lanthanum, terbium, lead 
and cadmium could bind to both types 
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5.4 Calmodulin and cadmium 
Cadmium has no known useful biological functions, and is toxic to humans, probably 
because it competes with zinc for binding sites and can therefore interfere with some 
of zinc's essential functions. In this way, it may inhibit enzyme reactions and 
utilization of nutrients. Cadmium may also be a catalyst to oxidation reactions, which 
can generate free-radical tissue damage. Although cadmium predominantly 
competes at zinc binding sites, reported effects on calcium ion channels (159)and it 
is known to affect the bones causing bone and joint aches and pains. It is also 
associated with weak bones that lead to deformities, especially of the spine, or to 
more easily broken bones which can be fatal in many cases. Cadmium toxicity 
threatens the health of the body by weakening the immune system by causing a 
decreased production of T lymphocytes (T cells) (160). Calmodulin in involved in 
the signal cascade to produce T cells (figure 1.16) and therefore it is possible that 
elevated levels of cadmium interfere with calcium uptake in calmodulin. These 
symptoms of cadmium toxicity, and cadmium's similarity in co-ordination number 
and size to calcium (151) suggest that it may also compete at calcium binding sites. 
5.4.1 Apo calmodulin and cadmium 
Cadmium was added to calmodulin from which the metal ions had been chelated by 
EGTA. Increasing concentrations of Cd(OAc) 2 were added to 25tM CaM, and 
analysed by nanospray on the Q-T0F. No binding of cadmium was seen to apo 
calmodulin, up to a concentration of 250 1xM. It appears from this result that 
cadmium does not have a strong affinity for either the EF hands or the auxiliary sites 
at these concentrations. 
5.4.2 Calmodulin calcium and cadmium 
Similar to the analysis of calmodulin with magnesium and strontium, cadmium was 
added to a sample of CaM from which the calcium had not been removed. The 
spectra (figure 5.23) show that CaM to which some Ca 2+ has bound will also bind 
Cd2t CaM in spectrum A shows two or more maximums in the charged ion series, 
mainly centred on -17 and -8. Overall the addition of Cd 2 shifts the charge 
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distributions towards -8 and a more conserved tertiary structure suggesting that the 
additional Cd2 is filling the vacant EF hands and forming a structure similar to 
CaM:4Ca. 
Deconvolution of the data shows definite increase in mass of the CaM when exposed 
to cadmium ions. However interpretation of the spectra is difficult due to the 
similarities in mass of cadmium (112.41 amu) and 3 calciums (120.23 amu) which is 
further complicated by the error in mass introduced by the 'assumption' that all the 
charges are from protons discussed in section 4.1.2. The deconvolution process 
means Cd2 addition is shown as a 110.39 Da increase and 3Ca 2 is shown as a 
114.19 Da increase. The resolution of the Q-ToF instrument used for these 
experiments is insufficient to resolve overlapping masses with 4 Da difference when 
analysing proteins with relatively high mass. 
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Figure 5.24 Deconvoluted spectra of CaM (A) to which increasing concentrations 
of Cd(OAc), has been added (B,C,D) 
Although the deconvoluted spectra give many permutations of Ca 2+ and Cd2 
addition, Cd2 is definitely binding to CaM. However it is inconclusive as to 
whether the cadium is binding to the EF hand or auxiliary sites. For instance the 
peak at -47190 could be CaM:lCa:4Cd, but could also be CaM:4Ca:3Cd, or a 
mixture of the two. In the former case 3 of the cadmiums may be binding into the EF 
hands, and the 4th  in an auxiliary site, although it is equally possible that the 4 
cadmiunis are all bindinc to auxiliary sites leaving 3 of the [F hands empty. 
lo investigate whether cadmium is capable of displacing calcium, a sample of holo 
calmodulin was analysed with varying concentrations of cadmium acetate. The data 
should be easier to interpret as if less than 4 Ca 2+  ions exist in one of the complexes, 
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Figure 5.26 Deconvoluted spectra of holo CaM (A) to which increasing 
concentrations of Cd(OAc)-, has been added (B.C) 
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As previously the similarity between the mass of 3Ca 2 and 1 Cd2 complicates the 
interpretation of the deconvoluted spectra and some peaks may be assigned more 
than one complex conformation. Nevertheless, it appears that cadmium displaces 
calcium. The peak at 17040 Da (green triangle) is assigned as CaM:3Ca:2Cd, and as 
the majority of the protein is initially in the CaM:4Ca form, one of the calcium ions 
must have been displaced to form this conformer. There is however a possibility that 
this peak is formed via the small amount of CaM:3Ca that is present in the initial 
solution, however the relative intensity of CaM:3Ca is small and is unlikely to 
account for the large relative intensity of the CaM:3Ca:2Cd peak. 
5.4.3 Calmodulin calcium cadmium and nNOS peptide 
To further probe whether CaM exposed to Cd 2 was forming the tertiary with the 
linker helix exposed available for binding to target proteins and peptides, nNOSpep 
was added to the sample. As shown in figure 5.27 below, no change in the charged 
ion series or mass increase was seen upon adding nNOSpep to the sample. Similarly 
the deconvoluted spectra, figure 5.28, show no increase in mass of 2433 Da. 
indicating binding of the nNOSpep. Upon addition of the peptide the signal is 
suppressed slightly and poorer resolution is achieved. Unusually no 
CaM:4Ca:nNOSpep was observed either. In the sample prior to addition of nNOS 
pep, various combinations of CaM:xCa:xCd are observed which are difficult to 
define. The deconvoluted masses shown are erroneous due to the deconvolution 
programme as described in section 4.1.2. This experiment was repeated with greater 
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Figure 5.27 Raw spectra of CaM + Ca(OAc)2 + Cd(OAc) 2 (A) to which nNOSpep 
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Figure 5.28 Deconvoluted spectra of CaM + Ca(OAc) 2 + Cd(OAc)2 (A) to which 
nNOSpep is added (B) 
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5.4.4 Cadmium conclusion 
Whether cadmium binds to the calcium binding sites of calmodulin and competes 
with calcium in inconclusive from the mass spectrometry results. The apo CaM does 
not appear to bind Cd2 , suggesting a low affinity to form the EF hands. When 
calcium is present in the CaM, Cd 2 associates to the protein. The shift in charge ion 
series suggests that the Cd 2 may be binding into the EF hands. This is supported by 
the apparent displacement of Ca 2 by Cd2 form the holo form of CaM. However 
when exposed to a proven peptide ligand, CaM exposed to Cd 2 does not form a 
complex. 
Cadmium ions have a very similar radius to calcium ions and the experiments carried 
out by Chao et al indicated that this similarity allowed Cd 2 to bind to CaM and 
prevent Ca2 binding (119). 
Unlike calcium which is a hard acid, Cd 2 is a soft acid and therefore will have 
different preferential ligating groups. In the EF hand sequence EKTTITGDGDKD, 
Cd2 will be able to form different interactions than Ca 2+ and may form additional 
interactions outside this sequence. Cadmium may therefore have a greater affinity 
than calcium for perhaps in a slightly removed site from the EF hand, but blocks the 
Ca 2+  from the EF hand sequence. The interactions it does form may not cause the 
structural changes necessary to expose the linker peptide to which nNOS binds. 
5.5 Calmodulin and Lead 
Lead toxicity is well historically well documented. One of the toxic pathways may 
be disruption of calcium mediated and calcium regulated functions. This may 
happen in a variety of ways: 1) direct interference with calcium transport; 2) 
indirectly altering cell functions required for calcium homeostasis; 3) by substituting 
for and mimicking the calcium ion at calcium binding sites (161). The effects of lead 
on calmodulin were therefore investigated by mass spectrometry to probe whether 
lead will cause the same structural change to apo calmodulin as calcium does, 
whether lead will displace calcium, and whether lead bound calmodulin will still 
form complexes. 
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5.5.1 Apo calmodulin and lead 
As previously, with magnesium, strontium and cadmium, lead acetate was added to a 
sample of calmodulin from which all ions had been chelated with EGTA. Lead 
acetate was added at various concentrations up to a ratio of 10:1 lead to calmodulin. 
No binding of lead to the apo calmodulin is observed until lead is in significant 
excess to calmodulin as can be seen from figure 5.29 below. 
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Figure 5.29 apo CaM (A) to which increasing concentration of Pb(OAc)2 has been 
added (B,C) 
Lead does not appear to have a strong binding affinity for apo calmodulin, however 
if is present in large enough excess will bind. It is ambiguous from these results 
whether lead cations are binding to the EF hands. At higher charge states there is an 
obvious preference for CaM:lPb and CaM:2Pb, which suggests that the EF hands of 
one calmodulin lobe is binding lead cations. However at lower charges states, where 
the structure may have a more compact conformation, there are 5 or 6 atoms of lead 
bound to the calmodulin. This may be lead binding to auxiliary sites or possibly 
adductation, as the compact structure offers more sites for lead to bind to. 
C 
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5.5.2 Calmodulin and calcium and lead 
Calmodulin from which calcium had not been chelated was exposed to lead acetate 
to probe the competition between calcium and lead for the EF hands and leads 
affinity for any auxiliary sites that may form on the holo calmodulin structure. 
Figure 5.30 shows the addition of increasing amounts of lead to calmodulin. Unlike 
apo CaM, the calciated CaM immediately binds lead, and apparently displaces 
calcium. At equal concentrations of lead and calmodulin, a variety of lead calcium 
calmodulin complexes can be seen. Additions of higher concentrations of lead result 
in more of lead binding to the complex. Up to 6 metal ions are seen bound as shown 
in figure 5.31. Above 4 metal ions, the lead must be binding to sites remote from the 
EF hands. Lead calcium CaM spectra are easier to interpret than those of Cadmium, 
as the larger mass of lead leads to greater resolution between the peaks. 
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Figure 5.31 	Deconvoluted spectra of holo CaM (A) to which increasing 
concentrations of Pb(OAc) 2 has been added (B,C,D) 
5.5.3 Calmodulin, calcium, lead and nNOS peptide 
To further probe the structure of the CaM:Pb:Ca complex, nNOS peptide was 
analysed with a sample of calmodulin which had previously been exposed to calcium 
and lead. 
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Figure 5.32 Raw spectra of CaM +Ca(OAc) 2 and Pb(OAc) 2 (A) to which 
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Figure 533 3 Deconvoluted spectra of CaM + Ca(OAc) 2 + Pb(OAc)2 (A) to which 
nNOSpep is added (B) 
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A mass increase equivalent to the mass of the peptide is seen for a calmodulin 
sample exposed to lead and nNOSpep. Binding of the peptide to CaM:xCa:xPb 
pertains to the retention of the structure and exposed hydrophobic regions. This 
suggests that lead ions are capable of displacing calcium completely from the EF 
hands and maintaining the overall tertiary structure of holo CaM. 
5.5.4 Lead conclusion 
Lead cannot bind to apo calmodulin unless present at high concentrations. Whether 
it binds to the EF hands of apo calmodulin is ambiguous. Lead can bind to calcium 
bound calmodulin at much lower concentrations than is required to bind apo 
calmodulin, and appears to displace the calcium from the EF hands when free lead is 
in higher concentration than calcium. There are other sites on calmodulin to which 
lead has an affinity when present in high concentration. Although lead has displaced 
calcium from the EF hand, the tertiary structure of holo calmodulin is retained, as 
seen by the preservation of a complex with the specifically binding nNOS peptide. 
This suggests that lead does not have the right parameters to form an EF hand around 
itself, however has the ability to displace lead once the EF hand has been formed. 
The divalent lead cation has a 25% larger ionic radii than calcium. This does not 
seem to affect its ability to fit into the EF hands, suggesting the EF hands are flexible 
and can expand to fit the larger ion whilst still complexing 
Lead cations are borderline acids, and share similar ligating properties to both hard 
and soft acids. Therefore it is possible that Pb 2 forms similar interactions to both 
	
2+ 	2+ 	 . Ca and Cd , maxi the number of associations that can be made between the 
i Pb 2+  on and the EF hand. These interactions may prove stronger than the 
interactions that calcium forms, although not strong enough to form the EF hand, 
Pb2 can displace the Ca 2 once it has formed. 
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5.6 Conclusions 
Overall CaM has a higher affinity for Ca 2+  than any of the other divalent metal ions 
studied. 
Divalent metal Binds apo Replaces Ca2 Auxiliary site 
CaM  binding 
Ca2 High - Yes 
Mg2 High No Yes 
Sr2 High No Yes 
Cd2 Low Yes Yes 
Pb2 Low Yes Yes 
Figure 5.34 Overview of divalent metal ion binding to CaM 
The results presented here show an initial insight into Calmodulin's affinity for 
divalent metal ions studied by ESIMS. However no apparent trends have been found 
to indicate a single dominant factor in cation affinity for CaM. Chao and co-workers 
suggested that ionic radii may be responsible for ability to bind to CaM, however the 
results shown here suggest that other factors such as coordination geometry and 
preferential ligating groups play an equally important role in selectivity and affinity. 
Figure 5.04, shows Ca 2+  binding to CaM to be cooperative as suggested by previous 
studies (43, 141, 153). Similar cooperativity is seen when Sr 2+ binds to apo CaM, 
suggesting that Sr2 can mimic calcium ion binding in the absence of calcium. 
However if calcium is available to CaM then it binds preferentially over strontium 
and strontium does not displace calcium from the EF hand. None of the other metals 
studied appear to mimic as calcium as effectively as strontium. Magnesium ions do 
not appear to bind in a cooperative manner, and there is no propensity for the 
CaM4Mg structure. If Mg 2+ does bind to the EF hands it does not cause the same 
structural changes as Ca 2+ binding causes. 
Cd2 and Pb2 however do not apparently bind easily to apo CaM but act similarly 
when exposed to CaM4Ca. They both are able to displace Ca 2+  from an EF hand if 
present in excess over Ca 2+  This may be one of their routes of toxicity, particularly 
at suboptimal concentrations of Ca 2 . This provides an alternative explanation to the 
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view that heavy metal toxicity is affects cellular reactions by interacting with 
essential sulfhydryl groups of target enzymes (119). 
Nevertheless, these experiments have been carried out in vitro and intercellular 
conditions are vastly more complicated. Mammilian cells contain millimolar 
glutathione which is capable of chelating heavy metals such as cadmium and lead 
and metallothioneins, whose synthesis is induced by the presence of heavy metals 
also effectively bind heavy metals as if to protect the cell (119). 
5.7 Further work 
These preliminary results show an insight into the affinity of different metal ions for 
CaM nevertheless more experiments are needed to investigate the exact behaviour of 
CaM when exposed to varying concentrations of metals. 
The difficulty in dealing with such small volumes of CaM and spiking with tiny 
volumes of metal acetate leads to poor repeatability and concentration errors. Such 
small volumes also require the use of nanospray, which as discussed previously 
(section 1. 1.3) can alter the charge distribution of a sample between needles. These 
problems could be overcome by accessing a greater supply of CaM and analysing the 
samples by ESIMS or perhaps by the use of a automated nanospray injection system 
(136). 
The difficulty in interpreting spectra and definitively assigning peaks to an exact 
number of metal ions could be overcome by the use of FT-ICRMS. Each metal has a 
unique isotope pattern and the powerful resolving power of the FT-ICRMS could be 
applied to identifying the complexes. 
HiD exchange could be employed to probe the structural changes if any that CaM 
undergoes when binding a metal ion, as changes in structure will affect the number 
of hydrogens available at the surface for exchange. 
Mutagenesis of amino acids in the EF hands could provide information on the sites 
that interact with Pb 2 and Cd2 , especially changing some of the basic sites in the EF 
hand which may decrease the affinity for these toxic metals. 
Further dissociation experiments could provide information on the binding strength 
of the metal ions for the sites they occupy on CaM. 
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6. Other non covalent complex forming systems 
Several other biologically relevant systems which involved non covalent interactions 
were analysed in the course of this work, two successful examples of which are 
detailed below. 
6.1 Human Double Minute 2 
A local pharmaceutical company, Cyclacel has collaborations with the Turner group 
at Edinburgh University. Cyclacel are investigating the properties of human double 
minute 2 (HDM2) protein as a potential cancer drug. 
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Figure 6.01 Sequence of HDM2 in one letter amino acid code. The 17 - 125 
region is highlighted in red. 
The 53 kDa phosphoprotein p53 is a multifunctional protein. 	One of its roles is in 
the regulation of cell proliferation by induction of cell cycle arrest or apoptosis, in 
response to DNA damage. Mutated and dysfunctional p53 is often associated with 
Other non covalent complex forming systems 
cancer development and 50% of all human tumours are found to contain a mutated 
form of this gene (162). P53 can form a stable complex with human double minute 2 
(HDM2) oncoprotein and in this bound state the HDM2 conceals the DNA binding 
domain of the p53  so that it is unable to activate the genes needed to induce cell 
cycle arrest or apoptosis. P53 and HDM2 form an autoregulatory feedback loop in 
which HDM2 inhibits p53, allowing survival of the cell, in turn p53 regulates the 
expression of HDM2
'
keeping the activity of p53 and levels of HDM2 in balance. 
Increased levels of HDM2, often seen in cancer can disturb this balance, completely 
inhibiting p53 and therefore promoting cell proliferation. 
Hence disruption of the interaction between HDM2 and p53 is a possible target for 
cancer therapy. The full sequence of HDM2 (55223 kDa) is given in figure 6.01, 
however only a fragment of this protein residues 17-125 were analysed. 
6.1.1 Analysis of HDM2 
HDM2 was analysed in 10 mM ammonium acetate buffer at 20 p.M on the 





Figure 6.02 Spectrum of HDM2 under optimal mass spectrometry conditions to 
obtain protein mass. Insert shows deconvoluted spectrum 
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The spectra produced figure 6.01 suggested the protein was in a partially folded state. 
The pH of the sample, and the ionisation conditions were varied to optimise the 
amount of folded protein, however this no improvement on the amount of folded 
protein shown on the spectra in figure 6.02 was achieved. 
The transformed data insert figure 6.02, shows a pure protein of mass 12520.5 Da. 
This correlates well with the mass calculated from the sequence of the 17 - 125 
fragment of HDM2. which is 12520.4 Da (82). 
6.1.2 HDM2 complexes 
A peptide supplied by Cyclacel was screened against HDM2 using the automated 
screen developed in section 3.8, to evaluate the peptide's affinity for the protein. 
if 
mti 
Figure 6.03 HDM2 and Cyclacel peptide in 10 mM NH40Ac 
Figure 6.03 spectrum shows the protonated peptide at 1897.5 m/z and the doubly 
charged peptide at 949.3 mlz. Peaks at 1044. 1138 and 1253 m/z. are unfolded 
HDM2. The complex only shows peaks in the 1 500 - 3000 m/z range and there is 
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no evidence of unfolded protein carrying a ligand. This suggests that the ligand is 
only bound to the folded protein which potentially to a tertiary structure pocket. 
Compared with figure 6.01 the ratio of folded to unfolded protein had increased in 
figure 6.02. This suggests that the ligand binding may be stabilising the protein in its 
folded conformation. 
A small molecule cyc13376, supplied by Cyclacel was also shown to bind to HDM2. 
20iM HDM2 and 20 tM cyc13376 were analysed in 10 mM ammonium acetate on 
the platform II mass spectrometer using the automated screen. Deconvoluted 
spectrum figure 6.03 shows that the small molecule does bind to HDM2 although 
with less affinity than the peptide shown previously. 
mass 
Figure 6.04 Deconvoluted spectrum of HDM2 and cyc 13376 
Mass spectrometry here provided supplementary information for Cyclacel in their 
research into HDM2 and its potential binders. This shows that the analysis of non 
covalent interactions and protein complexes by mass spectrometry is a powerful 
technique that may be of great advantage to the pharmaceutical industry. 
1'vI 
6.2 Cyclophilin 40 and CaM 
A larger complex was analysed to probe the ability to retain large complexes in the 
gas phase. Initially the cyclophilin A, calcineurin, calmodulin complex involved in 
immunosupression was chosen to be investigated. However insufficient quantities of 
protein were available at the time. Therefore the complex of cyclophilin 40 (Cyp4O) 
and calcineurin (CN) was investigated by electrospray ionisation mass spectrometry. 
Cyp40 is implicated in steroid receptor function through its association with heat 
shock protein 90 (HSP90) (163). The amino-terminal domain of Cyp4O, a 40 kDa 
protein, shares significant homology with CypA and exhibits the characteristic CsA 
binding and isomerase activity of CypA, though these activities appear to be less 
with Cyp4O than with CypA. The carbonyl-terminal domain incorporates 3 units of 
the tetraricopeptide repeat motif (163) and a putative CaM binding domain (164). 
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Figure 6.05 Sequence of Cyp4O in one letter amino acid code. The putative CaM 
binding domain is shown in blue and the CsA binding region which is 
structurally similar to CypA shown in red. 
6.2.1 Analysis of Cyp40 and CaM by ESIMS 
A sample of 150 .tM CaM and I OjiM Cyp40 in 1 OniM ammonium acetate under 
positive and negative ionisation conditions on the Micromass Q-ToF. Lower 
concentrations of CaM were initially tried, however no CaM or CaM:Cyp4O could be 
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Figure 6.07 Deconvoluted spectra of CaM and Cyp40 under positive and negative 
ionisation conditions. 
Under both positive and negative ion conditions the Cyp40:CaM complex is 
maintained and detected on the Q-T0F. The resolution of the complex is poor, and it 
is difficult to tell which conformations of CaM are involved in the binding. It is 
possible that other ions and molecules such as NH 4, H20 and Na are associating with 
the complex and causing heterogeneity to the observed mass of the complex, 
however such adducts have not been observed for the smaller complexes observed 
previously (section 4.1 .4) 
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6.3 Future Directions 
As seen by the wealth of literature and the number of non covalent systems studied 
there is a huge capacity for further work utilising electrospray ionisation mass 
spectrometry to analyses non covalent complexes. 
Recent publications have shown the application of native protein mass spectrometry 
for very large protein complexes consisting of many different proteins (165). Non 
covalent species with masses well over 1 million Dalton have been transferred into 
the gas phase (59). The analysis of such large complexes have been aided by 
instrumental development such extension of the mass range of quadrupole mass 
analysers (21). 
An impressive example of the analysis of heterogeneous protein complexes is the 
analysis of the stoichiometry of trytophan RNA binding attenuation protein (TRAP) 
in a complex with trytophan molecules. The protein is known to self assemble in 
oligomeric ring structures however the exact stoichiometry was unknown. 
McCammon et al (166) have used ESIMS to reveal previously known single and 
double ring structures of the TRAP assemble. Tandem MS on the single 1 2mer 
showed TRAP assemblies with 0, 6 and 11 tryptophan molecules bound. 
McCammon et al have used these results to propose a global quaternary model of the 
TRAP ring structure. 
The technique of ion mobility mass spectrometry is also being applied to the study of 
tertiary and quaternary structure of proteins. Gas phase electrophoretic molecular 
analysis (GEMMA) is a recent technique (167) that after ion generation, passes the 
ions through a chamber filled with ionised air, which reduces the charge on the 
molecule to singly charged or neutral species. In the subsequent ion mobility 
chamber the ions are separated by their time taken to drift a known distance through 
air, and the moblities have been shown to correlate well to the diameter of the 
measured species (165). 
The automated nanospray system mentioned in section 3.9, which uses a microchip 
device of 100 nozzles etched onto a silicon wafer in an attempt to produce a more 
stable and reproducible nanospray, will greatly aid and expand the investigation of 
non covalent complexes (135, 136). Nanospray tips can cause problems with 
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reproducibility and are time consuming to fill and use, and the use of these chips 
typically reduces analysis time, whilst maintaining a stable spray current. 
These recent developments have allowed larger and more complex protein 
assemblies to be investigated. A potentially interesting progression to the systems 
presented here is the analysis of the whole CaM:CN:CypA:CsA complex shown in 
figure 1.16. The whole complex is required to suppress the immune system and 
further investigation of the complex may results in a better understanding of 
immunosupression. 
6.4 Conclusions 
Non covalent complexes have successfully been maintained and analysed by 
electrospray ionisation mass spectrometry. It has shown that more information can 
be taken from mass spectrometry than simply molecular mass. The degree of 
charging observed on the protein and its complexes has provided insights into the 
structure which correlates well with information from other analytical techniques 
such as NMR and xray crystallography. 
The specificity of the technique has been highlighted by the targeted binding of 
nNOS to CaM4:Ca 2 and utilised to probe the proposed binding site of CaM to 
nNOS by the retention of the CaM:4Ca:nNOSpep complex. 
As described in section 3.8, this technique can be used to screen libraries of 
inhibitors and ligands for a desired protein quickly to provide initial affinity 
information. This is very desirable for pharmaceutical companies who require a test 
that can handle many samples in a short amount of time, and does not require a lot of 
sample. 
ESIMS has been shown to be an appropriate technique for coaxing the large, fragile 
ions of non covalent complexes into the gas phase without fragmentation or 
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